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Abstract 
 
 
 
LaNasa, Stephanie M. (Ph.D., Chemical Engineering) 
Department of Chemical and Biological Engineering, University of Colorado 
 
Development and Characterization of Porous and Patterned Hydrogel Scaffolds for Cardiac 
Muscle Tissue Engineering  
 
Thesis directed by Professor Stephanie J. Bryant 
 
 
 
Coronary heart disease has become increasingly prevalent in the U.S. and worldwide, and 
now affects over one million Americans annually. The damaged tissue that results from cardiac 
injury lacks the ability to regenerate, but no therapies exist to regenerate heart tissue. Tissue 
engineering is one promising method through which cardiac tissue could be regenerated. This 
research focuses on developing a tissue engineered hydrogel scaffold using a design regimen that 
facilitates nutrient transport, tensile properties, and cardiomyocyte adhesion and alignment. A 
porous structure incorporated into the bulk of the scaffold was selected as a means to enhance 
nutrient transport. Variations in hydrogel chemistry, crosslinking density and presence and size 
of pores between 50-200 µm allowed the scaffold properties to be tailored more closely to that of 
native tissue. Alteration of hydrogel formulation and chemistry of poly (ethylene glycol) (PEG) 
and poly (2-hydroxyethyl methacrylate) (pHEMA) led to increased strength or increased ultimate 
tensile strain. Towards designing hydrogels that promote cardiomyocyte adhesion, several 
proteins and peptides were examined. Results indicated that biological modification of the 
surface through covalent linkage of whole proteins, laminin or collagen I, supported cell 
spreading, the development of a contractile network, and phenotype. Interestingly, 
cardiomyocytes did not adhere to the cell-adhesive peptide sequence arginine-glycine-aspartic 
!iv!
!
acid (RGD), which is commonly employed to support cell attachment. Changes in stiffness of 
protein-modified hydrogels produced changes in cardiomyocyte gene expression of several genes 
important in maturation and disease pathways. However, the changes in gene expression based 
on stiffness and time did not indicate maturation nor disease on the substrates within the tested 
stiffness range. To mimic the aligned cellular architecture found in muscle, scaffolds were 
fabricated with an array of 3D surface channels with dimensions between 40-200 µm. Muscle 
cells cultured several layers thick and wide aligned within these channel structures, and 
alignment improved with decreases in channel width and increases in channel depth. These 
findings aid in development of a tissue engineered scaffold for cardiac muscle that can 
simultaneously incorporate architecture, mechanical properties and biological cues to promote a 
healthy cardiomyocyte phenotype. 
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Chapter 1 
 
Introduction 
 
1.1 Heart disease  
 
 
Heart disease is a leading cause of death in the U.S., affecting over one-third of adults 
throughout their lifetime
1
. Due to increasing obesity and an aging population, the rate of heart 
disease continues to grow
2
. A myocardial infarction, or heart attack, is a common result of heart 
disease. Since people are more likely to survive an acute heart attack than die
1
, a billion-dollar 
industry has been created to manage the side effects of the disease
3
.  
 
1.1.1  Myocardial infarction 
A myocardial infarction, commonly referred to as a heart attack, occurs when a coronary 
artery becomes occluded, reducing blood flow to part of the heart muscle. The contractile cells 
within the heart muscle, called cardiomyocytes, require high levels of oxygen due to the 
increased metabolic demands of continuous contraction. The reduced blood flow within a 
coronary artery during a heart attack leads to reduced oxygen supply to the cardiomyocytes, 
resulting in rapid cell death. In contrast to most tissues, cardiac muscle has little capacity to 
regenerate. Thus, survivors of myocardial infarction sustain chronic complications due to the 
permanently altered physiological state of the heart.  
Complications following a heart attack most often include thickening of the ventricular 
wall (ventricular remodeling), and abnormal signal conduction due to the increased electrical 
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resistance of scar tissue. In many cases, the pathologic hypertrophy of the ventricular walls 
continually worsens until the heart is unable to perfuse the body. This condition results in a 
common, fatal disease, known as congestive heart failure. 
 
1.1.2  Biology of the heart muscle 
Native heart muscle is composed of roughly one-third cardiomyocytes by number, but 
they make up over 80% of the total volume
4
. Fibroblasts, endothelial cells, pericytes, smooth 
muscle cells and macrophages are also present in the heart, and play important roles in 
supporting and maintaining the tissue
4
. This densely packed cellular network is surrounded by 
little extracellular matrix when compared to other tissues
5
. Instead, extracellular proteins are 
positioned between elongated muscle fibers, allowing for high levels of cell-cell contact 
necessary for cardiomyocyte gap junction formation and contraction (Fig. 1.1). The vasculature 
is of critical importance to the very metabolically active cardiomyocytes, and also winds between 
these cells, never more than 20 µm between capillaries in a rat model
6
.  
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Figure 1.1 The structure 
of cardiac muscle is 
made up of very densely 
packed muscle cells, 
which align end-to-end. 
Gap junctions, which 
allow action potentials to 
travel quickly from cell 
to cell, are located at the 
intercalated discs 
between adjacent muscle 
cells. As seen in the 
micrograph (b), the 
majority of the volume 
of cardiac muscle tissue 
is composed of 
cardiomyocytes. Image 
taken from 
harunyahya.com 
 
Although heart muscle has a high density of cells, the extracellular matrix plays many 
roles in maintaining proper structure, organization, and signaling pathways.  Some proteins that 
are known to play an important role in structure are collagens I and III, and elastin. The basal 
lamina contains collagens IV and VI, laminin, and fibronectin which help to regulate many cell-
adhesive functions
7
. 
 
1.1.3  Current therapies for heart attack victims 
Current therapies aim to alleviate the side effects caused by damaged heart muscle 
because no strategies presently exist to replace damaged tissue with regenerated, contracting 
cells. The most common treatments for heart attacks include medication, implantation of a 
mechanical or electrical assist device, or total replacement of the heart via whole-organ 
transplantation. Although a patient can regain functional tissue through a transplant, the need for 
hearts is much greater than the supply
8
. Just over 2,000 transplants annually have been 
  
! 4!
performed in recent years, but it has been estimated that over 20,000 individuals would benefit 
from a transplant
1,9
. A method for alternative replacement of tissue is a promising therapy for 
most patients, but is not currently available.  
 
1.2 Approaches for regeneration of heart muscle tissue 
 
1.2.1 Injectable therapies 
A variety of approaches have been explored for regeneration of heart muscle tissue. 
Injection of cells targeted towards the heart has been studied, and some cell sources, including 
autologous bone marrow cells
10
 and skeletal muscle cells
11
, have advanced to clinical trials. 
While many cell-only systems have shown promise
12
, injected cell therapies are highly 
dependent on cell type, often yield low long-term cell survival, and have sub-par results in 
humans
13,14
. Biologically active signaling molecules or growth factors, such as cytokines, are 
reported to have the ability to restore some function of cardiac muscle
15
.   However, injection of 
cytokines alone is not attractive since they lack the structural and regulatory advantages of cells. 
 
1.2.2  Tissue Engineering 
An improved approach for regenerating lost heart tissue function is through integration of 
cells into a biomaterial scaffold to create a tissue engineered ‘patch’. The scaffold aids in cell 
spatial arrangement and adhesion through attachment of extracellular matrix proteins, therefore 
mimicking components of the native tissue. It is critical that muscle cells receive the proper 
spatial cues to align, and a biomaterial scaffold’s architecture could be fabricated to promote 
alignment. Furthermore, cardiomyocytes in a scaffold can be conditioned for contractile function 
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in vitro, before implantation into the body. Many scaffold types can be fabricated to degrade 
over time, leaving only functional cells that have incorporated with healthy neighboring tissue. 
 
1.3 Tissue engineering heart muscle: current challenges 
 
1.3.1 Achieving appropriate cardiomyocyte densities 
The complex system of heart muscle produces many tissue engineering challenges. The 
first limitations arise from the inability to simultaneously achieve dense cardiomyocyte packing 
and good oxygen supply. While dense packing of cells can be achieved during seeding
16
, oxygen 
diffusion limitations cause cardiomyocyte death at distances greater than roughly 150 µm from 
the edge of the construct
17
. Perfusion studies through a porous cell-seeded scaffold have 
improved cardiomyocyte function and phenotype for larger ranges
18,19
, but perfusion systems 
could not be implemented in the heart itself.  
 
1.3.2 Cardiomyocyte adhesion to scaffolds 
Another specific challenge of engineering functional cardiac tissue stems from the need 
for cardiomyocytes to adhere to a biomaterial surface in an aligned pattern, to promote gap 
junction formation for contractile function. Cardiomyocytes have been successfully patterned on 
thin 2D surfaces
20-23
. However, thick, millimeter-scale tissue composed of aligned cells is needed 
to be clinically relevant as a cardiac patch. Furthermore, cells within the tissue engineered 
structures need to contract at a force similar to the heart, a goal current 3D muscle scaffolds have 
not reached
24
, likely due to imperfect alignment throughout the construct. 
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1.3.3 Cell sources 
Finding a suitable cell source for both in vitro studies, and ultimately, use in clinical 
trials, presents a third specific challenge towards cardiac muscle tissue engineering. Much work 
to date has employed neonatal rat ventricular myocytes, which are a well-established 
cardiomyocyte model but could not be used past in vitro testing. Stem cells from a variety of 
sources, including embryonic, bone marrow-derived, cardiac, and induced pluripotent, have been 
used in cardiac tissue engineering systems
25
, but will require years of further testing before they 
are deemed safe in humans. Many of the individual requirements for cardiac muscle tissue 
engineered constructs remain challenging to obtain in vitro. 
Neonatal rat ventricular myocytes are the standard cell source for three-dimensional 
cardiac muscle constructs, but skeletal muscle cells (C2C12) have demonstrated some utility as a 
screening tool. Skeletal myoblasts have been examined for their use in cardiac tissue engineering 
due primarily to one strong advantage over cardiomyocytes: they divide, allowing cell 
populations to regenerate. As muscle cells, they are capable of cytoskeletal alignment and can 
beat when paced. C2C12s have been used to examine a variety of seeding densities
16
 and 
attachment and differentiation patterns
26
 for 3-D cardiac muscle constructs, where subsequent 
cardiomyocyte seeding was successfully based upon the C2C12 results. Early studies exploring 
skeletal myoblast interaction with substrates of varying stiffness
27
 provided the basis for recent 
studies of cardiomyocyte-substrate interaction
28
. Vandenburgh and colleagues developed models 
for assembling skeletal myoblasts into organized structures and achieving contraction
29,30
, which 
could prove to be a very useful model to aid in cardiac muscle tissue engineering.  
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1.4 Biomaterials for cardiac muscle tissue engineering 
 
1.4.1 Scaffolds used in cardiac muscle tissue engineering 
Many initial scaffolds used to support cardiomyocyte cultures were made of natural 
materials and were often protein-based. Collagen I
16,31-34
 and Matrigel™
35,36
, a laminin-based 
mixture of proteins, have been extensively used both alone and as part of composite systems due 
to their cell-adhesive properties. These materials are intrinsically biocompatible, but lack tunable 
chemistry, architecture, and material properties. Seeding cells in a spatially controlled manner, 
and adjusting chemical, biological or mechanical properties is therefore very difficult. Although 
cells survive and contract within these gels, the scaffolds shrink dramatically with the force of 
the cells due to their extremely weak mechanical properties. 
 Many synthetic polymer scaffolds have also been investigated for use in cardiac muscle 
tissue engineering
17,20,37,38
. The ability to tailor the chemical interactions, degradation patterns, 
architecture, and cell-adhesive properties is advantageous. The importance of dynamic 
movement during culture of tissue engineered cardiac constructs necessitates the use of 
mechanically compatible materials as well. Although porous or PGA
37,39,40
 scaffolds were 
explored in early studies, specialized polymers have recently been developed to better match the 
tensile properties
41,42
 and anisotropic properties
22,43
 of the heart. Additional studies have explored 
the role of substrate stiffness in cardiomyocyte adhesion to biomaterial or cell substrates using 
polyacrlyamide gels
27
. 
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1.4.2  Hydrogels in tissue engineering 
Hydrogels are synthetic polymers that are hydrophilic, and do not dissolve in solution due 
to crosslinking between polymer chains. These materials often swell to many times their original 
size when in water. As such, they are compatible with the composition of the body. A wide 
variety of hydrogels have been developed for tissue engineering applications. Two materials that 
have been successful are poly(ethylene glycol) (PEG) and poly(2-hydroxyethyl methacrylate) 
(pHEMA)
44
. Each of these systems can be tailored to possess degradation patterns, mechanical 
properties, architectures and cell-adhesive properties to fit specific tissue engineering 
applications.  
The chemistries of these two polymers are different, but each is capable of forming a 
crosslinked network. Poly(ethylene glycol) (PEG) macromolecules may be functionalized for 
polymerization into a crosslinked network by reacting an acrylate or methacrylate group on each 
of the two ends of the PEG molecule. Upon polymerization, each PEG molecule covalently binds 
to neighboring molecules at two sites, creating a crosslinked network. Alternatively, each HEMA 
molecule contains one reactive methacrylate group, which can polymerize with neighboring 
molecules to form a long, but uncrosslinked, chain. Upon addition of a crosslinker containing 
methacrylate groups at two sites, the long pHEMA chains become crosslinked together to form a 
hydrogel. Both PEG and pHEMA hydrogels can be formed through photopolymerization, a 
process whereby light initiates formation of a free radical on a photoinitiator molecule, which 
consequently reacts with a monomer’s functional group and begins radical polymerization. 
Photopolymerization allows versatility in forming these networks. The precursor solution can be 
poured in any mold and exposed to light, forming a hydrogel with the shape and dimensions of 
the mold. Additionally, a photopattern, a mask that is transparent where polymer is to be formed 
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and opaque elsewhere, may be used to create features in the hydrogel by blocking light during 
polymerization. These unique features of photopolymerized hydrogels are advantageous in the 
development of hydrogels for tissue engineering, where specific architectures are often needed to 
improve cell viability or guide cell function. 
 
1.5 Promoting interaction between cardiomyocytes and biomaterials 
 
1.5.1  Myocyte adhesion to biomaterial surfaces 
Many cardiac muscle systems have employed whole proteins, or mixtures of whole 
proteins (Matrigel™), to promote cardiomyocyte adhesion to polymers or glass. Since 3D 
synthetic scaffolds do not naturally contain active biomolecules, cell adhesive proteins or their 
equivalent must be incorporated into the scaffold. Fortunately, cell-adhesive biomolecules may 
be tethered to synthetic scaffolds
45
. Some of the most common cell-adhesive proteins are 
laminin, collagen, and fibronectin, and cardiac muscle tissue engineering efforts have employed 
all three
21,31,46,47
.  
Since much of cell-adhesive protein functionality is a result of the Arginine-Glycine-
Aspartic Acid (RGD) peptide sequence, RGD can often be used in place of an entire protein with 
comparable results
48
. This sequence is biochemically reactive with integrins at the cell surface, 
promoting cell attachment. Integration of the RGD peptide sequence has achieved cell adhesion 
within several types of synthetic scaffolds
49-51
, making it a popular replacement for the 
incorporation of entire proteins into a scaffold.  This approach is advantageous because the RGD 
sequence is considerably more compact than an entire protein. The attachment of RGD to PEG is 
also well-characterized
49,52,53
. The RGD peptide has previously been attached to silicon 
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membranes to promote cardiomyocyte adhesion on a mechanically stretched substrate, but full 
myocytic morphology was not observed
54
.   
 
1.5.2  Alignment of cardiomyocytes on biomaterial surfaces 
Cardiomyocytes have been successfully patterned in 2D using a variety of methods that 
promote both adhesion and alignment. Patterned lanes of laminin micro-contact printed onto 
polyurethane films promoted cardiomyocyte alignment for widths of 15 µm
20
.  Fibronectin 
patterns of varied 2D shapes and dimensions were used to study cytoskeletal alignment, where 
sarcomeres best aligned when single cells or small clusters adhered to patterns of high aspect 
ratio near 7:1
21
. Fibronectin lanes 12 or 25 µm in diameter have produced cardiomyocyte 
adhesion and alignment with strong gap junctions when used with microgrooves 0.5-14 µm in 
diameter
22
. Although 2D protein micropatterned lanes have successfully promoted alignment 
within surfaces less than 30 µm in diameter, nanoscale features have recently been explored as a 
method to promote alignment of cardiomyocytes over greater areas. Nanoscale grooves of 800 
nm width and depth were found to promote cardiomyocyte focal adhesion density within the 
grooves, but also promote cardiomyocyte alignment along the axis of the grooves
23
.  
 
1.6 Mimicking native heart muscle 
 
1.6.1 Three-dimensional systems 
Cardiac organoids have been recently developed to achieve cardiomyocyte function in 
3D. Detachable sheets of cardiomyocytes, developed by Okano and colleagues, have formed the 
basis for many of these studies
55
. This initial method was attractive because cells detached 
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without disrupting gap junctions, and maintained contractile function apart from the original 
substrate
55
. Baar et al. developed cardiac organoids by forming a confluent cardiomyocyte and 
fibroblast layer on a laminin surface. As the cells remodeled the surface, the cell layer detached 
and formed a 100-µm thick organoid around a string in the culture
24
. Another study used 
alternating patterns of hyaluronan and fibronectin-coated glass to create smaller diameter (10 
µm) organoids
56
 where the majority of cells detached from the patterned surface.  
Organized growth of cardiac organoids while still attached to a scaffold has proven to be 
more difficult. PEG hydrogels were fabricated with channels between 100-200 µm, coated in 
Matrigel™, and pre- or co-cultured with fibroblasts and endothelial cells
57
. Contractile function 
of the myocytes was significantly improved for the pre-culture conditions, but required two 
supporting cell types.  
 
1.6.2 Mechanical and electrical conditioning 
In addition to cell adhesion molecules, surface patterns, and three-dimensional guidance, 
the formation of functional muscle tissue has improved with mechanical or electrical 
conditioning during culture
58
. Zimmermann and Eschenhagen seeded a mixture of 
cardiomyocytes, Matrigel™ and collagen I into rectangular molds, then electrically stimulated 
the constructs in culture to prove they were capable of pacing after more than one week
35
. 
Employing phasic mechanical stretch of 20% increased cell size and contractile force of 
cardiomyocytes within this experimental setup
59
. Further development of this system created a 
ring-like construct made of the same material, that was mechanically stretched and relaxed at 
10% for seven days, and showed signs of maturing cardiomyocytes with improved contractile 
function over non-stretched systems
59
. When these constructs were implanted into the heart, the 
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cardiomyocytes survived for eight weeks while maintaining contractile function
47
. The 
extracellular matrix structure of these engineered heart tissues allowed sufficient diffusion of 
oxygen to maintain viability of constructs where cells were located greater than 150 !m from the 
oxygen source. However, the cardiomyocyte density was lower in these constructs than in native 
heart, and therefore produced a lower force/area contraction
24
.   
Electrical conditioning has also been successful in promoting cardiomyocyte alignment 
and contraction. Improved protein levels, gene expression and contractile function were observed 
in cardiomyocytes seeded in tissue engineered constructs that had been electrically conditioned 
for several days to mimic heart conduction
5,60
. Often, improved contractile function of 
cardiomyocytes is reported for electrically conditioned cultures over control cultures through 
measurement of the excitation threshold (lowest voltage necessary to elicit synchronous 
contraction in "  75% of cells) and the maximum capture rate (highest frequency at which cells 
maintain synchronous contraction)
23,38,57
. 
 
1.7  Alternative uses of an in vitro cardiac muscle construct 
 
While a cell-biomaterial system for cardiac muscle could provide a promising therapy, it 
could also serve as a useful in vitro model. This system could be used to test cardiac cell 
response to signaling molecules towards better understanding heart disease and/or developing 
new drug therapies. Mimicking aspects of functional, arranged heart tissue in vitro would 
provide valuable screening tools for analysis of pharmacological molecules in a quicker, cost-
effective manner, prior to in vivo testing. 
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1.8  Moving forward in cardiac muscle tissue engineering 
 
Considerable progress has been made towards developing a heart-like tissue construct 
over the last decade, but many opportunities remain. A large number of systems are based fully 
or in part on natural materials that are poorly characterized, or incompatible with the mechanical 
properties of the heart. Often, the architecture of the biomaterial scaffold cannot be tailored for 
effective three-dimensional cell seeding, viability, and alignment. This thesis aims to develop 
hydrogel scaffold systems in which the architecture, mechanical properties, and incorporated 
biological groups can be tailored individually to meet the needs of cardiomyocytes. This will 
allow better mechanical compatibility between the biomaterial scaffold and the native tissue. It 
will also provide insight into promoting healthy phenotype of cardiomyocytes in contact with 
biomaterials, as well as techniques for spatially guiding cells towards alignment based upon 
changes to the scaffold architecture. 
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Chapter 2 
 
Objectives 
 
Although considerable progress has been made in the field of cardiac muscle tissue 
engineering, there remain many challenges that have not been fully overcome. A functional, 
contracting tissue patch must be composed of three-dimensionally arranged cardiomyocytes that 
are aligned end-to-end. These cells must receive sufficient levels of oxygen to remain viable 
within a tissue-engineered construct. The scaffold must have appropriate mechanical properties 
so as not to interfere with contractile function of the cells, or promote an undesirable phenotype. 
A hydrogel scaffold has the capacity to be tailored, so that many of these critical 
components of a cardiac muscle tissue engineering system can be individually studied, and then 
manipulated to guide cells towards alignment and proper phenotype. It is possible to tailor the 
architecture, mechanical properties and the incorporation of specific biological moieties into 
hydrogels. Additionally, hydrogels have high water content and do not produce harmful by-
products in the body, making them well-suited for biological applications. 
This research tests the hypothesis that porous hydrogel scaffolds with appropriate 
mechanical properties, biological function, and aligned open channels support muscle cell 
attachment, maintenance of a healthy phenotype, and alignment in three dimensions. To test this 
hypothesis, this thesis has four main objectives which are to 1) elucidate the impact that pores 
and their size have on mechanical properties towards tailoring a scaffold suitable for matching 
mechanical properties of native myocardium, 2) investigate how the type of protein or peptide 
used to biologically modify hydrogels impacts cardiomyocyte adhesion and phenotype towards 
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designing a scaffold to support a healthy cardiomyocyte phenotype, 3) describe the impact of 
scaffold stiffness on cardiomyocyte adhesion and phenotype, such that the mechanical properties 
of the scaffold will promote healthy cardiomyocyte phenotype 4) determine if muscle cells can 
be induced to align when seeded within 3D channels, and characterize the impact of channel 
dimensions on alignment. Poly(ethylene glycol) (PEG) and poly(2-hydroxyethyl methacrylate) 
(pHEMA) are two hydrogels that have tunable mechanical properties, methods for attachment of 
biological moieties, and have been used in conjunction with photopatterning techniques and the 
creation of macropores. These properties make PEG and pHEMA systems attractive for 
development of cardiac tissue engineered scaffolds. 
 
Objective 1  
 
The first objective was to determine suitable polymer compositions of PEG or pHEMA, 
as well as a range of pore sizes, that could be incorporated into hydrogel scaffolds to maintain 
mechanical properties resembling those of the native tissue. Porosity is desirable within tissue 
engineered scaffolds to promote diffusion of oxygen and nutrients to the cells, as well as a way 
to better incorporate grafts in vivo. For this work, a sphere-templating method was chosen to 
incorporate pores that are much larger than the intrinsic PEG or pHEMA hydrogel pores (~50-
200 µm). To briefly explain sphere templating, a network of polymer spheres is packed and 
sintered to melt contacting edges together. A monomer solution is poured around the spheres, 
then polymerized to form a crosslinked network. The spheres are dissolved away with acetone, 
leaving behind monodisperse, interconnected pores within the crosslinked polymer. This method 
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can effectively promote transport of oxygen and nutrients to cardiomyocytes, but also has the 
ability to promote angiogenesis, and therefore, graft survival, if implanted in vivo. 
 Both poly(ethylene glycol) (PEG) and poly (2-hydroxyethyl methacrylate) (pHEMA) 
hydrogels have been commonly used as biomaterials and were well suited for use in our cardiac 
tissue engineered system because of their compatibility with both channel and pore formation 
techniques.  It was hypothesized that each polymer system would have a different response to 
changes in crosslinking density, as their basic structures and hydrophilicity are different. The 
incorporation of pores was expected to decrease the strength of the scaffolds, but increase the 
amount a scaffold could stretch under tensile loading. The tensile mechanical properties of 
hydrogel scaffolds were measured in response to crosslinking density of the polymer and the size 
of the pores incorporated into the scaffold. Interactions between these two variables were also 
examined. 
 
Objective 2  
 
 Cardiomyocytes are most commonly seeded within collagen I or Matrigel! solutions in 
tissue engineering applications, where they successfully adhere and spread. Individual cell-
adhesive proteins such as Collagen I, laminin or fibronectin have been deposited on glass or 
biomaterial scaffolds to promote cell adhesion, spreading and striation. While hydrogel-based 
scaffolds have many advantages in tissue engineering, they lack the cell-adhesion moieties 
necessary for cell recognition. However, cell adhesion proteins and oligopeptides can be 
incorporated into synthetic PEG or pHEMA scaffolds with high fidelity, using well-characterized 
chemistries. We hypothesized that a cell-adhesive Arginine-Glycine-Aspartic Acid (RGD) 
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peptide could be used in place of a whole protein to obtain the same cell-adhesive results that 
promote cardiomyocyte adhesion to proteins. The use of a small peptide provides superior 
control to a protein in a hydrogel system, since it allows for incorporation of a known number of 
cell adhesion sites, but one specific cell adhesive chemistry. Adhesion of several cell types to 
hydrogels has been promoted through conjugation of the RGD peptide to a hydrogel.  
For this work, a 2D hydrogel surface was modified with the whole proteins collagen I or 
laminin, or the cell-adhesive peptide RGD at high (5 mM) and low (0.5 mM) concentrations. 
Prior to becoming functional, contracting cells, cardiomyocytes must demonstrate good viability, 
adhesion, cytoskeletal arrangement and phenotype. These measures were analyzed through 
comparison of live cell counts on each modified surface, immunohistochemical evaluation of the 
cytoskeletal structure and attachment sites as observed through Troponin I and vinculin, and 
evaluation of gene expression profiles of cardiomyocytes on each modified scaffold type over 
time. 
 
Objective 3  
 
Key findings from the first two objectives allowed us to tailor porous hydrogels to fit 
mechanical properties of contracting muscle, and to successfully modify the surface of hydrogels 
to encourage viability, adhesion and phenotype of cardiomyocytes. The third objective for this 
research was to combine the necessary hydrogel mechanical (aim 1) and biological properties 
(aim 2) to better analyze how scaffold stiffness at the interface between the cell and hydrogel 
affects cardiomyocyte viability, gene expression, and cytoskeletal structure. 
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Although we have modified hydrogels such that we can tailor the bulk properties, we 
have observed they are very sensitive to differences in their immediate surroundings. In our 
previous studies, peptide sequences elicited a very different response than whole proteins, as 
observed through cytoskeletal arrangement and gene expression.  Other studies have indicated 
changes in myotube differentiation or contractile function based upon the stiffness of the 
substrate on which the myocytes are cultured. 
To better characterize and develop a hydrogel system for use with cardiomyocytes, 
changes in crosslinking density of a hydrogel system were adjusted such that the moduli of the 
scaffolds spanned a large range (~300 - 5000 kPa). The specific system used was a pHEMA 
hydrogel with covalently-bound collagen I, based upon findings from objectives 1 and 2. In a 
diseased heart, stiffness increases due to increased load. Therefore, it was hypothesized that the 
structure and gene expression of the cardiomyocytes would more strongly retain characteristics 
of healthy, developing cardiomyocytes on softer substrates, whereas more stiff substrates would 
promote cardiomyocyte structure and phenotype more characteristic of a disease state. This 
hypothesis was tested through analysis of gene expression and cytoskeletal structure within 
cardiomyocytes seeded onto three distinct sets of hydrogels of different stiffness. 
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Objective 4  
 
In order for a muscle tissue-engineered construct to develop strong enough contractile 
force and be clinically relevant, muscle cells must be arranged in three dimensions. The fourth 
objective was to analyze the response of muscle cells arranged in 3D within hydrogel surface 
channels of varying dimensions. Cell alignment on the scaffold is critical to achieve the 
necessary end-to-end junction formation between cells that allows them to contract 
synchronously. Many studies have investigated cardiomyocyte alignment on patterned 2D 
surfaces or microscale grooves. However, larger features are favorable for 3D arrangements 
where thicker, aligned aggregates could generate greater force. The channel structure for these 
studies was specifically designed to maximize cell density, maintain alignment, and maintain 
viability. A skeletal muscle cell line (C2C12) was chosen for preliminary screening of cell 
response to these channel dimensions due to the higher cell numbers that could be used within 
short time frames during these studies. We hypothesized that muscle cells could be guided to 
align within thick and deep channels (on the order of 40-200 µm), but a limit would be reached 
where the channels were too wide to promote alignment.  
 Channels were created by making a mold using a thiol-ene chemistry capable of 
obtaining high aspect ratios, then using the mold to spatially pattern channels into a hydrogel 
scaffold during polymerization. Skeletal muscle cells were seeded in channels up to 200 µm 
wide and 100 µm deep. The cell response was analyzed through observation of alignment based 
upon orientation from the channel wall for cells at different spatial locations throughout the 
channel. The overall orientation of cells within each channel, as well as the effect of cell location 
on alignment, was observed.  
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Furthermore, the ability of C2C12 skeletal myoblasts to differentiate into myotubes was 
observed during this study. It was hypothesized that MHCIIb, a myosin heavy chain isoform 
whose production is upregulated as differentiation into myotubes occurs, could be used to track 
the timeline and differentiation potential of myoblasts into myotubes for different channel 
dimensions, to evaluate whether the level of alignment within channels corresponded to changes 
in the timeline needed to achieve differentiation. This was tested through immunohistochemical 
staining of MHC IIb, as well as the gene expression profile of MHC IIb over time, for cells 
within channels of widths varied between 40-200 µm.  
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Chapter 3 
 
Presence of pores and hydrogel composition influence tensile properties of scaffolds 
fabricated from well-defined sphere templates 
 
(As appears in The Journal of Biomedical Materials Research, Part B, (2010), In press) 
 
Sphere templating is an attractive method to produce porous polymeric scaffolds with 
well-defined and uniform pore structures for applications in tissue engineering. While high 
porosity is desired to facilitate cell seeding and enhance nutrient transport, the incorporation of 
pores will impact gross mechanical properties of tissue scaffolds and will likely be dependent on 
pore size. The goals of this study were to evaluate the effect of pores, pore diameter, and 
polymer composition on gross mechanical properties of hydrogels prepared from crosslinked 
poly(ethylene glycol) (PEG) and poly(2-hydroxyethyl methacrylate) (pHEMA). Sphere 
templates were fabricated from uncrosslinked poly(methyl methacrylate) spheres sieved between 
53-63 and 150-180 !m. Incorporating pores into hydrogels significantly decreased the quasi-
static modulus and ultimate tensile stress, but increased the ultimate tensile strain. For pHEMA, 
decreases in gel crosslinking density and increases in pore diameters followed similar trends. 
Interestingly, the mechanical properties of porous PEG hydrogels were less sensitive to changes 
in pore diameter for a given polymer composition. Additionally, pore diameter was shown to 
affect skeletal myoblast adhesion whereby many cells cultured in porous hydrogels with smaller 
pores were seen spanning across multiple pores, but lined the inside of larger pores. In summary, 
incorporation of pores and changes in pore diameter significantly affect the gross mechanical 
properties, but in a manner that is dependent on gel chemistry, structure and composition. 
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Together, these findings will help to design better hydrogel scaffolds for applications where 
gross mechanical properties and porosity are critical. 
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3.1       Introduction 
 
 
  Hydrogels are attractive materials for tissue engineering due to their compliant 
mechanical properties, water-based composition, and tunable chemistries. Control of the 
macroscopic properties via crosslinking density, as well as introduction of macroporous 
structures within the hydrogel, afford a flexible platform for designing scaffolds for a range of 
applications. Hydrogels have small intrinsic pores, on the order of tens of nanometers, resulting 
from their crosslinked polymeric structure, which facilitate oxygen and nutrient transport. 
However, larger pores are often a key design feature to support cell seeding post-fabrication and 
which will further enhance nutrient transport, particularly of large biomolecules. 
Hydrogels fabricated with pore sizes ranging from several microns to several hundred 
microns have been studied in tissue engineering, with varied levels of success depending on pore 
size and cell type
1,2
.  Many fabrication techniques have been developed to achieve pores within 
this range, including porogen leaching
3-5
, phase separation
6
, gas foaming
7
 and three-dimensional 
printing
8,9
. The size and shape of pores vary greatly depending on the fabrication technique and 
often result in irregularly shaped pores spanning a range of sizes. More recently, sphere 
templating was developed to introduce monodisperse and uniform pores into a polymer 
network
10,11
.  This process is similar to porogen leaching where a precursor solution fills the void 
space of a 3-dimensional template, in this case, consisting of densely packed and fused 
microspheres, which are then dissolved away. This technique allows for precise control over 
pore structure and pore size, offering a platform from which to probe the role of pore size in 
mediating cellular response in a highly controlled environment. For example, spherical pores that 
were between~20 and 60 !m in diameter within poly(2-hydroxyethyl methacrylate) hydrogels 
have led to enhanced healing
12
 as shown by improved vascular ingrowth
13
, reduction of fibrotic 
!!
! 30 !
scars
14
 and reduced intraocular pressure
15
, in comparison to pores of larger or smaller 
dimensions, or non-porous materials. 
 Porous scaffolds, in particular those prepared from sphere-templating, are being explored 
for applications such as the development of vascular grafts
16-18
, engineered muscle tissue
19,20
, and 
skin
21,22
. For these applications, the tensile properties of the scaffold are critical to the initial 
function of the construct in vivo. However, pore structure and pore size will have a large impact 
on gross mechanical properties. For example, the compressive mechanical properties of 
crosslinked elastin hydrogels were impacted by pore interconnectivity, size and spatial 
distribution
23
, while tensile properties of anisotropic porous polyurethane scaffolds were affected 
by changes in void fraction and pore alignment
24
. A separate study employed sphere-templating 
to create low moduli porous fibrin hydrogels, but observed no difference in tensile properties 
over small ranges in pore diameters
18
. Taken together, these studies and others underscore the 
importance of better understanding the role of pores and pore size on the gross mechanical 
properties when designing porous scaffolds for applications where material mechanics are 
important to overall scaffold function. 
Therefore, the goals of this study were to assess the impact of pores, pore diameter, and 
polymer composition on the gross mechanical properties of hydrogels prepared from crosslinked 
poly(ethylene glycol) (PEG) and poly(2-hydroxyethyl methacrylate) (pHEMA). PEG and 
pHEMA hydrogels have been extensively studied for tissue engineering
25,26
, including strategies 
requiring porous hydrogels
27-31
. Sphere-templating was employed as a platform from which to 
probe the impact of pore diameter on tensile properties, because it allowed for fabrication of 
uniformly-shaped, near monodisperse pores. Specifically, two sphere-templates with average 
sphere diameters of ~58 !m and ~163 !m were chosen to produce porous hydrogels relevant for 
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tissue engineering applications. The large pore size was chosen because it is within the optimal 
range for tissue engineering applications,
32
 while the smaller pore size was chosen because it is 
within the range that leads to reduced fibrotic scarring
12
.  The hydrogels were characterized by 
their equilibrium swelling content and their porous structure. Tensile mechanical properties, 
specifically quasi-static modulus, ultimate stress, and ultimate strain, were evaluated as a 
function of pore presence, pore diameter, and polymer composition.  Finally, the effects of pore 
diameter on cellular attachment and adhesion were evaluated using skeletal myoblasts as a model 
cell type.  
 
 
3.2  Materials and methods 
 
3.2.1  Fabrication of sphere templates 
Uncrosslinked poly(methyl methacrylate) (PMMA) microspheres (Polysciences, Inc) or a 
PMMA/ poly(ethyl methacrylate) blend (Vicki Peters Acrylic Powder, Kupa, Inc) were sieved to 
obtain fractionates ranging between 53 and 63 !m and between 150 and 180 !m.  Spheres were 
poured into a dog-bone shaped, 0.8 mm thick Teflon! mold that was modified per ASTM 
standard D638 (12 mm gauge length, 5 mm at thinnest width, and 5 mm curvature radius) and 
sandwiched between two glass slides. The sphere-packed molds were placed in a sonicator 
(VWR, Model 150T) for two 30 min intervals, then sintered for 19 hr at 140°C to fuse the 
microspheres which form interconnects between adjacent spheres. 
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3.2.2  Fabrication of porous hydrogels 
 To fabricate poly(2-hydroxyethyl methacryate) (pHEMA) hydrogels, monomer solutions 
were prepared from 50, 65 or 80% (v/v) 2-hydroxyethyl methacrylate (HEMA) (Polysciences, 
Inc), tetraethylene glycol dimethacrylate (1 mol HEMA: 0.02 mol TEGDMA), 1.5% (w/w) 2,2-
dimethoxy-1,2-di(phenyl)ethanone photoinitiator in a solution of 43% ethylene glycol and 57% 
water by volume. Poly(ethylene glycol) (PEG) hydrogels were fabricated by one of two methods. 
For the higher crosslinked gels, monomer solutions were composed of 65 or 80% (v/v) 
polyethylene glycol diacrylate (PEGDA) (Polysciences, Inc, MW 508) and 1.5% (w/w) 
photoinitiator in a 43% ethylene glycol and 57% water solution by volume. The solutions were 
sonicated for two hours and placed on a shaker overnight. For the low crosslinked PEG 
hydrogels, monomer solutions were composed of 20% (w/w) PEGDA (MW 3000) and 0.2 % 
(w/w) photoinitiator in a 43% ethylene glycol and 57% water solution by volume. PEGDA was 
synthesized in our lab as previously described
33
 and  91% of the end groups of PEG were 
determined to be functionalized with acrylate groups. 
Monomer solutions were poured into dog-bone molds, both with and without sphere 
templates, and photopolymerized for 5 min on each side at 365 nm and an intensity of 4 
mW/cm
2
, (UVP, model XX-20BLB).  To dissolve the sphere template, the polymer was removed 
from the mold, and placed in a solution of 90% acetone:10% water for 48 hrs on an orbital 
shaker, changing the solution a minimum of three times. We have previously determined that 48 
hours is sufficient to completely dissolve the sphere template, as indicated by visible inspection 
whereby the hydrogel becomes translucent in water, and by imaging the pores via scanning 
electron microscopy. Following dissolution of the sphere-template, the hydrogels were 
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subsequently rinsed in a 50% acetone:50% water solution for several hours followed by rinsing 
3X in deionized water for 24 hours on an orbital shaker. 
 
3.2.3  Equilibrium swelling 
  Equilibrium swelling ratios were determined from non-porous hydrogels fabricated as 
described above.  Hydrogel sheets were equilibrated in water for 24 hr at room temperature, then 
punched into 5 mm diameter and 0.8 mm thick discs. The swollen discs were weighed (ms) 
(n=6), lyophilized for 48 hr, and weighed again to obtain the dry weight (md). The equilibrium 
mass swelling ratio (q=ms/md) was calculated and then converted to an equilibrium volumetric 
swelling ratio (Q) using known densities of the uncrosslinked polymer and solvent. The percent 
equilibrium water content was also determined by (ms-md)/ms*100%. 
 
3.2.4  Tensile testing 
 After equilibrating in deionized water for 24 hours at room temperature, gauge length, 
gauge width and thickness were measured for each dog-bone shaped scaffold in the hydrated 
state.  Each sample was tested under tension on a material tester (MTS Synergie 100, 10N load 
cell) at a strain rate of 0.15/ min. Load (g) and displacement (mm) were recorded and the 
engineering stress and strain were determined (n = 6-12). The quasi-static modulus was 
evaluated within the lowest 75% of the curve prior to reaching the elastic limit.  
 
3.2.5  Scanning electron microscopy and dimensional analysis 
 Porous hydrogels were cut in cross-section with a sharp razor while hydrated and then 
dried for 24 hr under high vacuum. To visualize the porous structure, cross-sections were imaged 
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using low vacuum scanning electron microscopy (LVSEM) (JSM-6480LV) at an acceleration of 
1 kV.  SEM images of dried polymer cross-sections were analyzed using Image J Software (NIH, 
Bethesda, MD).  Dimensions of internal pore diameters were measured (n=15/scaffold) and 
averaged over three scaffolds for each hydrogel composition.  The void fraction of each porous 
hydrogel cross-section (n = 3) was estimated by outlining the void space of each cross-section, 
and dividing by the total area of the hydrogel cross-section as measured using Image J.  
 
3.2.6  Cell Studies 
 Porous PEG (MW 508) scaffolds with pore diameters of either 63-75 or 150-180 !m 
were soaked in a 100 mg/mL collagen I solution for 30 min at RT, then rinsed with phosphate-
buffered saline. Each scaffold (6 mm wide x 6 mm long x  .15 mm deep) was seeded with 
100,000 skeletal myoblasts (C2C12, ATCC CRL-1772) between passages 5-15, then centrifuged 
at 1,000 RPM for 10 min. Scaffolds were cultured in Dulbecco’s Modified Eagle’s Medium 
(DMEM, ATCC 30-2002) with 10% FBS for 48 hours. A live/dead cell viability kit (Invitrogen) 
was used to image cell location, morphology and viability within open pores.  
 
3.2.7  Statistical Analysis 
 
A two-way ANOVA was performed using a general linear model in Minitab to determine 
significance for quasi-static modulus, ultimate stress and ultimate strain, as a function of gel 
composition. Data are reported as mean +/- standard deviation or standard error of the mean. 
Statistical significance was determined at p < 0.05. 
 
 
!!
! 35 !
3.3      Results 
 
For porous hydrogels in their hydrated state, water will imbibe the open pores as well as 
contribute to swelling of the polymer.  Therefore, hydrogels were initially characterized by their 
equilibrium volumetric swelling ratios in the absence of macroscopic pores to provide a measure 
of the degree of crosslinking associated with the polymer. PEG hydrogels fabricated from high 
molecular weight precursors resulted in the highest degree of swelling (Q = 6.73) with an 
equilibrium water content of 85%. All other PEG and pHEMA formulations (Table 3.1) 
exhibited equilibrium volumetric swelling ratios ranging from 1.60 to 1.85, corresponding to 
37% to 46% water content, respectively. As expected, swelling ratios decreased with increasing 
monomer concentration in the precursor solution prior to polymerization for both PEG and 
pHEMA hydrogel formulations.  
 
Table 3.1. Hydrogel formulation and characterization for porous hydrogels prepared from sphere-
templating 
Monomer 
Weight 
percent 
monomer in 
solution 
Crosslinking 
Density 
Designation 
Equilibrium 
volume swelling 
ratio (Q)** 
Sieve 
Range 
(!m) 
Pore Size 
Designation 
Dehydrated 
Dimensions 
(SEM) 
(!m)***   
Estimated 
Hydrated 
Dimensions 
(!m) 
PEG3000DA 20 Low 6.73 ± 0.56 53 - 63 small 31 ± 2 60 
PEG400DA 65 Medium 1.85 ± 0.00 53 - 63 small 54 ± 4 70 
PEG400DA 80 High 1.63 ± 0.00 53 - 63 small 51 ± 3 70 
HEMA* 49 Low 1.66 ± 0.01 53 - 63 small 46 ± 4 50 
HEMA* 64 Medium 1.65 ± 0.00 53 - 63 small 58 ± 7 70 
HEMA* 79 High 1.60 ± 0.00 53 - 63 small 53 ± 5 60 
        
PEG3000DA 20 Low  6.73 ± 0.56 150-180 large 96 ± 5 230 
PEG400DA 65 Medium 1.85 ± 0.00 150-180 large 155 ± 14 190 
PEG400DA 80 High 1.63 ± 0.00 150-180 large 161 ± 9 210 
HEMA* 49 Low 1.66 ± 0.01 150-180 large 117 ± 9 150 
HEMA* 64 Medium 1.65 ± 0.00 150-180 large 147 ± 5 170 
HEMA* 79 High 1.60 ± 0.00 150-180 large 147 ± 12 190 
        
* TEGDMA was added as crosslinker (0.02 mol TEGDMA: 1 mol HEMA) 
**   ± Reported as SEM; Q values were determined from non-porous hydrogels. 
*** ± Reported as SD   
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LVSEM images of dehydrated porous scaffolds revealed spherical, interconnected pore 
structures throughout the hydrogels (Fig. 3.1). The pore structure appeared relatively 
monodisperse throughout the bulk of each scaffold with less than 10% variation in average pore 
diameter for hydrogels prepared from either of the two sphere-templates (53-63 µm or 150-180 
µm). Dimensional analysis indicated pore diameters were near the expected range, based on 
sieve size (Table 3.1). However, hydrogel formulation did impact the dehydrated (p < 0.0001) 
and estimated hydrated pore dimensions. When hydrated, the average pore diameters increased 
by 10-30% for all formulations, except for the 3000 PEGDA formulation, which resulted in 
~100% increase due to the high degree of swelling.  The estimated hydrated pore size ranged 
from 50 to 70 !m for hydrogels prepared from small sphere-templates and from 150 to 230 !m 
for hydrogels prepared from large sphere-templates.  
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Figure 3.1. Representative scanning electron microscopy images of cross-sections for 
porous PEG hydrogel scaffolds (a-f) and porous pHEMA scaffolds (g-l) prepared from 
different formulations.  Porous scaffolds were prepared from small sphere-templates (53-
63 µm) (a-c, g-i) or from large sphere-templates (150-180 µm) (d-f, j-l).  The 
formulations correspond to equilibrium swelling ratios for PEG, 6.73 (a,d), 1.85 (b,e), 
and 1.63 (c,f), and for pHEMA 1.66 (g,j), 1.65 (h,k) and 1.60 (i,l). 
 
Representative stress-strain curves for several hydrogel formulations without and with 
pores showed distinctly different profiles, although all exhibited a linear, elastic region (Fig. 3.2). 
For all PEG hydrogel formulations, both non-porous and porous scaffolds broke abruptly upon 
reaching their ultimate stress and strain values. Contrarily, for all pHEMA hydrogel 
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formulations, the non-porous and porous scaffolds experienced significant necking resulting in a 
fracture stress that was ~50% lower than the ultimate stress. 
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Figure 3.2. Representative quasi-static stress-strain curves to failure for PEG and pHEMA 
hydrogels consisting of no pores, small pores (53-63 µm) and large pores (150-180 µm) for 
different formulations. The formulations correspond to equilibrium swelling ratios for PEG of 
6.73 (a), 1.85 (b) and for pHEMA of 1.65 (c). Each representative curve falls within the standard 
deviation. 
 
From the stress-strain curves, the mean quasi-static modulus, ultimate stress and ultimate 
strain were determined and are presented in Fig. 3.3 with corresponding statistical analysis in 
Table 3.2. For PEG scaffolds, hydrogel composition and pores impacted quasi-static modulus 
(Fig. 3.3b), ultimate stress (Fig. 3.3d), and ultimate strain values (Fig. 3.3f). The average quasi-
static tensile moduli values of PEG scaffolds with lower crosslinking density (Q=6.73) were 
approximately five-fold lower than the corresponding scaffolds with higher densities (Q=1.85-
1.63). Incorporating pores into the PEG scaffolds significantly decreased the moduli values, but 
interestingly there was no difference among the two pore diameters investigated. Overall, PEG 
composition and pores significantly impacted modulus and there was a significant interaction 
between composition and pores. 
 
 
!!
! 39 !
"!
0
0.2
0.4
0.6
0.8
1
1.2
1.4
Low
(Q = 1.66)
Medium
(Q = 1.65)
High
(Q = 1.60)
No pores
Small pores
Large pores
Q
u
a
s
i-
s
ta
ti
c
 M
o
d
u
lu
s
 (
M
P
a
)
pHEMA Hydrogel Crosslinking Density
 
#!
0
2
4
6
8
20
22
24
26
28
30
Low
(Q = 6.73)
Medium
(Q = 1.85)
High
(Q = 1.63)
No pores
Small pores
Large pores
Q
u
a
s
i-
s
ta
ti
c
 M
o
d
u
lu
s
 (
M
P
a
)
PEG Hydrogel Crosslinking Density
 
$!
0
0.1
0.2
0.3
0.4
0.5
Low
(Q = 1.66)
Medium
(Q = 1.65)
High
(Q = 1.60)
No pores
Small pores
Large pores
U
lt
im
a
te
 S
tr
e
s
s
 (
M
P
a
)
pHEMA Hydrogel Crosslinking Density
 
%!
0
0.5
1
1.5
2
2.5
Low
(Q = 6.73)
Medium
(Q = 1.85)
High
(Q = 1.63)
No pores
Small pores
Large pores
U
lt
im
a
te
 S
tr
e
s
s
 (
M
P
a
)
PEG Hydrogel Crosslinking Density
 
e 
0
0.2
0.4
0.6
0.8
1
1.2
Low
(Q = 1.66)
Medium
(Q = 1.65)
High
(Q = 1.60)
No pores
Small pores
Large pores
U
lt
im
a
te
 S
tr
a
in
pHEMA Hydrogel Crosslinking Density
 
&!
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
Low
(Q = 6.73)
Medium
(Q = 1.85)
High
(Q = 1.63)
No pores
Small pores
Large pores
U
lt
im
a
te
 S
tr
a
in
PEG Hydrogel Crosslinking Density
 
Figure 3.3. Mean mechanical properties of pHEMA and PEG hydrogels 
showing quasi-static modulus (a,b), ultimate stress (c,d) and ultimate strain (e,f).  
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Table 3.2. Statistical analysis for hydrogel mechanical properties. 
Factor Measure SS MS VR P-value 
pHEMA Composition Modulus 3.99 1.99 23.1 < 0.001 
 Max stress 0.148 0.074 9.15 < 0.001 
 Max strain 2.24 1.12 63.2 < 0.001 
Pore Size Modulus 6.22 3.11 36.0 < 0.001 
 Max stress 0.923 0.462 57.0 < 0.001 
 Max strain 0.903 0.451 25.4 < 0.001 
Interaction Modulus 1.05 0.262 3.03 < 0.05 
 Max stress 0.055 0.014 1.71 Not significant 
 Max strain 0.541 0.135 7.62 < 0.001 
      
Factor Measure SS MS VR P-value 
PEG Composition Modulus 2100 1050 61.4 < 0.001 
 Max stress 13.3 6.65 31.7 < 0.001 
 Max strain 3.89 1.94 135 < 0.001 
Pore Size Modulus 1960 982 57.5 < 0.001 
 Max stress 15.7 7.83 37.3 < 0.001 
 Max strain 0.166 0.083 5.8 < 0.01 
Interaction Modulus 944 236 13.8 < 0.001 
 Max stress 7.65 1.91 9.1 < 0.001 
 Max strain 0.449 0.112 7.82 < 0.001 
* Two-way ANOVA; SS, Sum of squares; MS, Mean square; VR, Variance 
 
A similar finding was observed for the ultimate stress of PEG scaffolds, which was 
impacted by both composition and pores. Ultimate stress was approximately 10-fold lower for 
the low crosslinked gels compared to PEG gels with higher crosslinking. The incorporation of 
pores significantly reduced the ultimate tensile stress, but there was no difference among the two 
pore sizes. There was a significant interaction between composition and pores for ultimate stress. 
As expected, the ultimate tensile strain of the PEG scaffolds exhibited opposite trends 
compared to the modulus and ultimate stress. PEG scaffolds with the lowest crosslinking density 
experienced the largest strain with strains reaching up to 0.35 before failure. Incorporation of 
pores significantly increased the strain to failure by ~100%. The higher crosslinked PEG 
scaffolds experienced significantly reduced strains with ultimate strains reaching only ~0.10. 
Pore diameter did not significantly impact the ultimate strain. Overall, PEG composition and 
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pores affected ultimate strain values and there was a significant interaction between composition 
and pores. 
For pHEMA scaffolds, both hydrogel composition and pores impacted quasi-static 
modulus (Fig. 3.3a), ultimate stress (Fig. 3.3c), and ultimate strain values (Fig. 3.3e). While 
differences in equilibrium volume swelling ratios were small, hydrogel composition had a 
significant impact on the tensile properties. An increase in crosslinking density resulted in a 
significant increase in the quasi-static modulus by ~150% and ultimate stress by ~70% over the 
range studied. The incorporation of pores led to a significant reduction in the modulus and 
ultimate stress values, which were further affected with increasing pore diameter. There was a 
significant interaction between crosslinking density and pore structure for the tensile modulus, 
but not for ultimate stress. 
P(HEMA) scaffolds experienced significantly greater strains when compared to PEG 
scaffolds. The ultimate strains were highest in the lowest crosslinked pHEMA hydrogels with the 
largest pore diameters, which reached strains over 1. Overall, as the crosslinking density 
increased, ultimate strain values decreased significantly. The ultimate strain increased with the 
incorporation of pores and subsequently with increased pore diameter.  There was a significant 
interaction between the crosslinking density of pHEMA and the pore structure for the ultimate 
tensile strain values. 
The porosity was determined for each hydrogel formulation and sphere-template using 
cross-sectional areal measurements from SEM images (Table 3.3). The porosity was generally 
higher for hydrogels formed from the larger sphere-template when compared to the smaller 
sphere template for a given hydrogel formulation. The ultimate stress for each hydrogel 
formulation and sphere-template was adjusted, taking into account the reduced cross-sectional 
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area from the porous structure. The data (Table 3.3) indicate ultimate stress values that were 
more representative of the values corresponding to the non-porous hydrogels. 
    
Table 3.3. Porosity values and adjusted ultimate stress for porous hydrogels. 
Monomer 
Weight 
percent 
monomer in 
solution 
Porosity* 
Ultimate stress 
(non-porous) 
Adjusted 
ultimate 
stress** 
Ultimate stress 
(porous) 
53-63 !m 
PEG3000DA 20 0.59 ± 0.04 0.217 0.27 0.111 
PEG400DA 65 0.72 ± 0.03 2.22 1.92 0.54 
PEG400DA 80 0.62 ± 0.03 1.98 1.76 0.67 
HEMA 49 0.55 ± 0.00 0.258 0.21 0.094 
HEMA 64 0.57 ± 0.01 0.288 0.27 0.114 
HEMA 79 0.68 ± 0.02 0.427 0.65 0.208 
150-180 !m 
PEG3000DA 20 0.72 ± 0.01 0.217 0.36 0.1 
PEG400DA 65 0.72 ± 0.02 2.22 1.86 0.52 
PEG400DA 80 0.76 ± 0.00 1.98 2.25 0.54 
HEMA 49 0.69 ± 0.02 0.258 0.21 0.064 
HEMA 64 0.70 ± 0.00 0.288 0.24 0.071 
HEMA 79 0.84 ± 0.03 0.427 0.56 0.090 
      
 
*Determined based on SEM measurements of areal porosity in the dehydrated state 
**Estimated ultimate stress values based on solid fraction and estimated swollen solid volume 
 
The porous scaffolds were also evaluated for their ability to support cell attachment and 
adhesion (Fig. 3.4). Porous PEG scaffolds prepared from the medium crosslink composition (Q = 
1.85) were soaked in a collagen I solution post-fabrication to promote cell attachment. Skeletal 
muscle cells were seeded into porous scaffolds and their viability and morphology were assessed. 
Skeletal myoblasts attached well to both porous scaffolds, remaining viable after 48 hours. 
Interestingly, myoblasts cultured in the smaller pores demonstrated an ability to span across 
multiple pores. However, myoblasts cultured in the larger pores were seen lining the interior of 
the pores and in some cases had formed multiple cell layers along the pores (Fig. 3.4).  
!!
! 43 !
!
a 
 
b 
 
Figure 3.4. Skeletal muscle cells cultured within porous PEG hydrogel scaffolds 
prepared from (a) large sphere-templates (150-180 !m) and (b) small sphere-
templates (63-75 !m) exhibited differences in morphology that were dependent on 
pore size. Cells can be seen lining the inside of the large pores while cells can be 
seen spanning across pores within the smaller pores. Live cells were stained with 
Calcein AM and are shown in green, while the porous hydrogel auto-fluoresced 
red. 
 
 
3.4      Discussion 
 
While compressive and tensile testing has been explored for PEG and pHEMA 
hydrogels, few comprehensive studies have investigated the effects of polymer composition and 
pore diameter simultaneously. By employing the sphere-template technology with well-defined 
pore structures, our overall findings indicate that tensile mechanical properties are dependent on 
the chemistry (PEG versus pHEMA), crosslinking density, presence of pores, and pore diameter. 
Overall, our findings confirm that incorporating pores and optimizing pore diameter for a 
particular application significantly impacts the gross mechanical properties, but in a manner that 
is dependent on the chemistry and structure of the hydrogel.  
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The structure and chemistry of PEG and pHEMA hydrogels differ quite dramatically as a 
result of the multifunctional precursors employed as well as differences in polymer-solvent 
interaction. PEG is formed from high molecular weight macromers while pHEMA is formed 
from low molecular weight monomers and tetrafunctional crosslinkers. In addition, PEG is more 
hydrophilic than pHEMA resulting in PEG chains which are surrounded by water and maximally 
swollen, while non-covalent, hydrophobic interactions between pHEMA chains prohibit the 
hydrogels from reaching a maximally-expanded state in water
34
. These differences likely 
contribute to the large variations observed in the mechanical properties and failure mechanisms 
between crosslinked PEG and pHEMA. Most notably, the high crosslinked PEG hydrogels 
exhibited moduli nearly 20-fold higher and strains which were ~one-fourth (~0.1) that of 
pHEMA hydrogels even though the swelling values were within a similar range (Q~1.6-1.65). In 
addition, failure in the PEG hydrogels occurred abruptly upon reaching the ultimate stress, 
whereas the pHEMA hydrogels were capable of larger deformations that led to necking and a 
lower fracture stress when compared to the ultimate stress. Further changes in crosslinking 
density impacted the mechanical properties as expected, whereby a decrease in the crosslinking 
density, as evidenced by the increase in swelling, resulted in lower moduli and stress values, but 
increased strains.  
As expected, introduction of pores into the network reduced the quasi-static modulus and 
ultimate stress, but increased ultimate strain. Porous pHEMA hydrogels were sensitive to 
changes in pore diameter and responded with large differences in modulus, ultimate stress and 
ultimate strain. Porous PEG hydrogels however, responded with minimal changes in mechanical 
properties over a fairly large range of hydrated pore diameters averaging from ~50 to ~200 !m. 
This phenomenon is likely due to differences in the water-swollen polymer structure as described 
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above. While differences were observed in the fracture behavior between porous PEG and 
porous pHEMA, the fracture area examined by scanning electron microscopy (data not shown) 
showed clean breaks across the transverse. 
 To gain a better understanding into the impact of pores on mechanical properties, the 
void fraction was estimated for each hydrogel formulation and sphere-template. Based on a 
model of perfect hexagonally-packed spheres, it is expected that the void fractions would be 74% 
for hydrogels formed from either the small or large templates. The average void fraction 
determined for scaffolds prepared from the larger sphere-template was ~75%. However, the 
average void fraction for scaffolds prepared with the smaller sphere-template was significantly 
lower and was ~60%. One factor that may have contributed to the differences observed in the 
void fractions is the size distribution of the sphere fractionates. The large sphere fractions 
spanned a wider range of spheres (~30 !m) compared to a more narrow fractionate range for the 
small spheres (~10 µm), where a wider range of spheres can lead to better packing as the smaller 
spheres are able to fill void spaces. When the cross-sectional area associated with the solid 
fraction of polymer was used to determine ultimate tensile stress, the adjusted values were within 
20% of the values reported for the non-porous hydrogels. These findings further confirm that the 
porous structure led to the reduction in ultimate stress and moduli observed in Figure 3.3.  
This study highlights the role of pores, pore diameter, and polymer chemistry and 
structure in impacting the quasi-static modulus, ultimate tensile stress and ultimate tensile strain 
in hydrogels prepared from crosslinked PEG and pHEMA. Due to structural differences in their 
crosslinked structure and their chemistry, different bulk properties were observed between PEG 
and pHEMA hydrogels. These differences greatly affected the magnitude by which pores and 
pore diameter impacted the gross mechanical properties. Interestingly, the mechanical properties 
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of porous pHEMA hydrogels were highly sensitive to changes in pore diameter, while 
mechanical properties of porous PEG hydrogels were not sensitive to changes in pore diameter 
over the size range studied. It should be noted that the glass transition temperature of the 
crosslinked polymers will also impact the mechanical properties; although all of the hydrogels 
examined in this study exhibited some degree of rubbery behavior. In addition, the presence of 
water has been shown to significantly reduce the glass transition of hydrogels
35
, which together 
indicate that the hydrogels studied here are above their glass transition temperature.  Overall, 
increases in gel crosslinking density led to higher modulus and ultimate tensile stress values, 
while the incorporation of pores supported large strains. Taken together, this study aims to help 
better design hydrogels for applications in tissue engineering where both mechanical properties 
and porosity are critical. 
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Chapter 4 
 
 
Influence of ECM proteins and their analogs on cells cultured on 2D hydrogels for cardiac 
muscle tissue engineering 
 
(As appears in Acta Biomaterialia 5(8):2929-38 (2009))  
 
 
This study assessed the role of immobilized cell adhesion moieties on controlling cellular 
attachment, adhesion, and phenotype of cardiac muscle cells towards developing scaffolds for 
cardiac muscle tissue engineering. Collagen I, laminin, and the cell-adhesive oligopeptide, 
Arginine-Glycine-Aspartic Acid (RGD) at 0.5 and 5 mM concentrations were covalently bound 
to flexible 2D hydrogels. A robust skeletal myoblast cell line demonstrated good bioactivity for 
the modified hydrogels resulting in myoblast attachment and development of an intracellular 
contractile network after 1 day. Primary neonatal rat ventricular myocytes cultured for up to 7 
days, however, were more sensitive to the different modified substrates. Although total 
cardiomyocyte DNA content did not vary significantly with surface modification, 
immunostaining for the contractile protein Troponin I and focal adhesion protein vinculin 
revealed marked improvements in spreading and intracellular contractile protein deposition for 
cells attached to protein-modified hydrogels over those modified with RGD, regardless of RGD 
concentration. On the RGD-modified surfaces, cardiomyocytes self-associated forming 
aggregates that exhibited a disorganized cytoarchitecture. Cardiomyocyte maturation was 
assessed through the fetal gene program where expression for atrial natriuretic peptide decreased 
and sarco(endo)plasmic reticulum Ca
2+
 increased with culture time for the protein-modified 
surfaces indicating a trend towards maturation, while the !/"-myosin heavy chain ratio remained 
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near fetal expression levels for all surfaces. Overall, our findings suggest that whole proteins, 
collagen and laminin, are effective in promoting cardiomyocyte interaction with hydrogels and  
cardiomyocyte maturation while RGD does not provide adequate extracellular matrix cues for 
cardiomyocytes.  
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4.1  Introduction 
 
Nearly eight million Americans each year experience a myocardial infarction
1
 and must 
cope with the side effects of compromised heart muscle function. Cell transplantation therapies 
have shown promise for improving heart function after myocardial infarction
2
, but have several 
shortcomings. Most notably, only a small fraction of transplanted cells survive long-term, the 
overall success of cell transplantation is varied and highly dependent on the cell type used, and 
the results have been less than optimal in humans
3,4
. The use of a 3D cell carrier may help 
overcome many of these shortcomings. Through combining the benefits of cell transplantation 
with the structural guidance of a 3D scaffold, myocardial tissue engineering offers a promising 
and exciting alternative therapy for creating a patch of living cardiac muscle.  
Towards engineering the myocardium, several scaffold chemistries have been 
investigated from naturally-occurring systems, including alginate
5
, collagen type I,
6
 
7-9
 gelatin,
10
 
fibrin,
11,12
 and Matrigel!6, to synthetic systems, including polyurethane13,14, poly(glycolic acid) 
15,16
, poly(lactide) co-polymers
17
, and poly(glycerol sebacate)
18
. Synthetic scaffolds offer many 
advantages over natural scaffolds due to the ability to tailor their mechanical properties and 
degradation rates. For synthetic-based scaffolds, a number of studies have focused on designing 
scaffolds with elastomeric properties towards mimicking the mechanical properties of the heart
18-
20
. These materials are often hydrophobic where cell attachment is driven by non-specific protein 
adsorption
21
. However, studies have reported that cardiomyocyte adhesion and organization into 
a contractile tissue have been far superior on natural scaffolds compared to synthetic scaffolds
6,22
 
To circumvent this shortcoming, suspending cells in Matrigel", collagen or fibrin gel within the 
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pores of synthetic materials has shown improved cardiomyocytes performance within synthetic 
hydrogels
23,24
.   
Interestingly, there have been few efforts focused on immobilizing bioactive groups to 
synthetic scaffolds for cardiac muscle tissue engineering. A few studies have shown that proteins 
present in the basement membrane of the myocardium, e.g. laminin, promote cardiomyocyte 
adhesion in 2D cultures
13,25
. An alternative to using whole proteins to promote cell adhesion to 
synthetic scaffolds is to incorporate cell adhesive oligopeptides enabling precise control over 
ligand presentation and density. The oligopeptide, arginine-glycine-aspartic acid (RGD), is the 
most commonly used cell adhesion peptide because it is found in a number of adhesion proteins 
including fibronectin, vitronectin, laminin and collagen type I 
26
. Many cell types demonstrate 
good adhesion to synthetic scaffolds immobilized with RGD and often with comparable results 
to the full protein
27
.  
The goal for this study was to assess the role of immobilized cell adhesion moieties on 
controlling cellular attachment, adhesion and phenotype of cardiac muscle cells. Cells were 
grown on flexible two-dimensional hydrogel substrates based on poly(2-hydroxyethyl 
methacrylate) (poly(HEMA)) and poly(ethylene glycol) (PEG) immobilized with full proteins or 
oligopeptides. Hydrogels formed from poly(HEMA) and PEG are particularly attractive because 
they do not promote protein adsorption or cell adhesion, thereby acting as a blank platform to 
which bioactive groups may be incorporated in a highly controlled manner. Specifically, we 
explored two proteins which are present in the native myocardium, collagen type I, an interstitial 
protein, and laminin, a basement membrane protein, and the oligopeptide, RGD, which is a cell 
adhesion site present in both collagen type I and laminin. Hydrogels were initially screened with 
a skeletal myoblast cell line, which served as a robust type of muscle cell to test cell attachment 
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to the bioactive hydrogels and from which to compare the more sensitive primary 
cardiomyocytes. Cell attachment was assessed by total DNA content while cell adhesion and 
phenotype were examined by immunofluorescence for contractile and focal adhesion proteins. 
Cardiomyocyte phenotype was further assessed through gene expression for proteins involved in 
the fetal gene program, which has been used as an indicator of both cell maturity as well as a 
pathological phenotype
28
. Findings from this study will aid in designing suitable synthetic 
hydrogel scaffolds for cardiac muscle tissue engineering.  
 
4.2  Materials and methods  
 
 
4.2.1  Fabrication of 2D hydrogel films  
Hydrogel films were fabricated by two different methods depending on the incorporation 
of oligopeptides (i.e. RGD) or full proteins (i.e., collagen I or laminin).  
For hydrogels immobilized with RGD, poly(ethylene glycol) diacrylate (PEGDA) (MW 
3000) was synthesized as previously described
29
 and verified through 
1
H NMR (Varian YVR-
500S). The peptide sequence, NH3-Tyr-Arg-Gly-Asp-Ser-COOH (YRGDS, BaChem), was 
reacted with acryloyl-PEG-NHS (MW 3400, Nektar Therapeutics) in a 50 mM sodium 
bicarbonate buffer, pH 8.4, for two hours at room temperature. The product, acryloyl-PEG-RGD, 
was dialyzed and lyophilized for 48 hours. Percent conjugation was determined by use of a 
fluoraldehyde reagent (Pierce Biotechnology). The acryloyl-PEG-RGD macromer at 
concentrations of 0.5 or 5 mM was incorporated into a solution comprised of 20% w/w PEGDA 
and 0.12% (w/w) photoinitiator (1-[4-(2-hydroxyethoxy)-phenyl]-2-hydroxy-2-methyl-1-
propane-1-one, Irgacure 2959, Ciba Specialty Chemicals) in distilled, deionized water.  The 
solution was poured between two glass slides spaced 0.8 mm apart, polymerized under 365 nm 
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UV light (6 mW/cm
2
) for 10 minutes, and rinsed in a DI water bath overnight. Individual 5 mm 
diameter discs were punched from the hydrogel films, soaked in 70% ethanol for 2 hours, then 
rinsed four times in sterile PBS.  The moist hydrogels were stored in a sterile, sealed container at 
4°C until use. 
For protein-modified hydrogels, a macromer solution was prepared by combining 6.7 % 
(w/w) poly(ethylene glycol) dimethacrylate (MW 3000), which was synthesized as described 
elsewhere
29
, 81.5 % (w/w) 2-hydroxyethyl methacrylate (HEMA, Polysciences, Inc),  0.17% 
photoinitiator (1-hydroxy-cyclohexyl-phenyl-ketone, Irgacure 184, Ciba Specialty Chemicals) in 
a 57% DI water: 43% ethylene glycol solution. HEMA was chosen because it contains a pendant 
hydroxyl group within each repeat unit, which can be readily modified with proteins after 
hydrogel fabrication 
30
. The solution was poured between two glass slides coated with a thin 
layer of glycerol to prevent the hydrogel from adhering to the glass surface, spaced 0.8 mm 
apart. The solution was polymerized under 320-500 nm UV light (5 mW/cm
2
) for 15 min. The 
hydrogel was soaked in a DI water bath overnight. Individual 5 mm discs were punched from the 
hydrogel films, sterilized with 70% ethanol for 2 hours, and dried under high vacuum for 2 
hours.  The free hydroxyl groups were reacted with 100 mM CDI in dry acetone, as described 
previously 
30
. Collagen Type I (rat tail, Upstate Cell Signaling Solutions, 3.56 mg/ml) or laminin 
(Upstate Cell Signaling Solutions, 1.6 mg/ml) was diluted in sterile PBS to create a protein 
solution at a concentration of 667 µg/ml. Hydrogel discs were placed each in 0.8 ml chilled 
protein solutions for 48 hrs on an orbital shaker. Hydrogels were transferred to sterile PBS and 
stored at 4°C until use. 
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4.2.2  Cardiomyocyte isolation 
Hearts were isolated from 1-2 day old Fisher rat pups (Charles River Laboratories), 
according to a protocol approved by the University of Colorado’s Animal Care and Use 
Committee.  Cardiomyocytes were isolated from hearts as previously described
31
. Briefly, 
minced ventricles were gently shaken overnight at 4° in a solution of 0.6 mg/ml trypsin, followed 
by a five-interval tissue digestion in a 1 mg/ml Collagenase II (Worthington Biochemical) 
solution. Cells were pre-plated for 45 min to remove cardiac fibroblasts and enrich the cell 
population for cardiomyocytes
31
. 
 
4.2.3  Cell seeding 
Unmodified hydrogels or hydrogels modified with RGD or proteins were placed in 
individual wells of a 48 well plate and pre-soaked with culture medium overnight. Skeletal 
myoblasts, C2C12s (ATCC, CRL-1772) at passage 6-10 were seeded onto the hydrogels or a 
gelatin-coated TCPS control at a density of 25,000 cells/cm
2
 in Dulbecco’s Modified Eagle’s 
Medium (ATCC, 3002) supplemented with 10% Fetal Bovine Serum (Hyclone). Skeletal 
myoblasts were cultured for 24 hours prior to analysis. For cardiomyocyte studies, freshly 
isolated cardiomyocytes were seeded directly into wells coated with 0.1% gelatin as a positive 
control for cardiomyocyte attachment or directly onto peptide- or protein-modified hydrogels. 
Specifically, enriched cardiomyocytes were resuspended in growth medium (MEM, Gibco 
11575-032, 50U/ml penicillin-G, 1.5 µM vitamin B12, 5% fetal calf serum (Hyclone), 0.1 mM 
Bromodeoxyuridine (BrdU)) and seeded at a density of 185,000 cells/cm
2
. Cardiomyocytes were 
allowed to settle for 24 hours. Medium was exchanged at 24 hours with serum-free medium 
(MEM, .1% (w/w) BSA, transferrin, selenium, and .1 mM BrdU) and exchanged daily thereafter.
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4.2.4  Brightfield microscopy  
Cells were imaged in culture at 24-hour intervals post-seeding with a Nikon Eclipse 
TE300 microscope at 10x and 20x magnification. 
 
4.2.5  DNA quantification  
Wells were rinsed with 0.5 mL phosphate-buffered saline (PBS) solution. Hydrogels 
were removed from culture (n=3) and placed in 300 µl cell lysis buffer (20 mM Tris, 2 mM 
EDTA, 150 mM NaCl and 0.5% Triton-x-100 in DI water), then incubated for 10 min at room 
temperature. The lysate was removed from individual wells and stored at -80°C until analysis. 
Total DNA on each hydrogel was quantified with a Quant-it Pico Green kit (Invitrogen). 
 
4.2.6  Immunohistochemistry   
Hydrogels were removed from culture medium, rinsed in PBS, and fixed in a 4% 
paraformaldehyde solution for 20 minutes at room temperature. Hydrogels were stored in 15% 
sucrose for 24 hours. Dehydrated hydrogels were rinsed in PBS and placed in a 0.5% Triton-X 
solution for 5 min, blocked in PBS with 10% goat serum, 3% BSA, and 0.25% Triton-X for 60 
min at room temperature. To assess skeletal myoblast attachment and structure, hydrogel 
surfaces were treated with anti-tropomyosin 1:400 (Sigma, T2780) primary antibody and 
Alexafluor 546 goat anti-mouse 1:400 (Invitrogen, A11030) as the secondary antibody. To assess 
cardiomyocytes, hydrogel surfaces were treated with rabbit anti-Troponin I 1:100 (Chemicon, 
AB1627) or mouse anti-vinculin 1:400 (Sigma V9131) primary antibodies for one hour at room 
temperature. Alexafluor 488 goat anti-rabbit (Invitrogen, A11034) or Alexafluor 546 goat anti-
mouse (Invitrogen, A11030) was then applied at a dilution of 1:400, respectively. Cells treated 
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with anti-vinculin were additionally treated with Alexa 488 phalloidin 1:20 for 20 min. All 
hydrogels were then counterstained with DAPI 1:1000 (Invitrogen, D1306) and imaged hydrated 
with confocal microscopy (Zeiss LSM5 Pascal). 
 
4.2.7  Real-time RT-PCR  
Minced rat heart sections were frozen immediately with liquid nitrogen, combined with 
Tri Reagent! (Sigma) and homogenized, then stored at -80°C. RNA was isolated from samples 
per manufacturer’s instructions. RNA was quantified with a Quant-it Ribogreen RNA kit 
(Invitrogen). cDNA was synthesized with a High-Capacity cDNA Reverse Transcription Kit 
(Applied Biosystems). Cardiomyocytes cultured on gelatin-coated TCPS control wells, or on 
protein- or peptide-modified hydrogels were treated according to manufacturer’s instructions 
with a Fast SYBR Green Cells-to-CT kit for RNA isolation and cDNA synthesis (Applied 
Biosystems). Forward and reverse primers developed for the fetal gene program
32
 were used: 
18S (housekeeping gene), "-Myosin Heavy Chain, #-Myosin Heavy Chain, atrial natriuretic 
peptide (ANP) and sarco(endo)plasmic reticulum Ca
2+
 ATPase (SERCA2a). Samples were run 
on ABI Fast7500, in 9600 Emulation mode, and analyzed by relative expression of the gene of 
interest to the housekeeping gene (n=5). 
 
4.2.8   Statistical analysis 
Samples were compared using a two-sample T-test assuming unequal variance. Values 
were reported as the mean ± standard deviation. A value of p < 0.05 was considered statistically 
significant. 
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4.3  Results 
 
4.3.1  Skeletal myoblast adhesion to peptide modified hydrogel  
C2C12 skeletal myoblasts were seeded onto hydrogel substrates, which were unmodified 
or  modified with collagen type I, laminin, or RGD prepared at concentrations of 0.5 or 5 mM. 
Gelatin-coated TCPS was used as a positive control for cell attachment. Myoblast attachment 
and adhesion were analyzed after 24 hours of culture. Light microscopy images (data not shown) 
illustrated good cell adhesion on all biologically-modified hydrogels, but few cells adhered to the 
unmodified hydrogel surfaces. Total DNA content was used as a measure of cellular attachment. 
Myoblast total DNA quantification agreed with brightfield images, yielding significantly higher 
DNA content for all biologically-modified hydrogels compared to the unmodified hydrogel (Fig. 
4.1).  Total DNA content was statistically similar among all modified hydrogels and was similar 
to gelatin-coated TCPS.  
 
 
 
 
Figure 4.1. Cell attachment and 
growth was measured by total DNA 
content for skeletal myoblasts cultured 
on gelatin-coated TCPS, unmodified 
hydrogels, and hydrogels modified 
with collagen, laminin, or RGD after 
24 hours of culture. * or # above a 
column indicates significance from 
TCPS control or unmodified hydrogel, 
respectively, on the same day; p ! 
0.05. 
 
 60 
Myoblast adhesion, spreading, and cytoskeletal organization were assessed through 
immunohistochemical detection of sarcomeric tropomyosin, a muscle-specific protein (Fig. 4.2). 
Both protein and peptide-modified hydrogels promoted good myoblast adhesion. No cells were 
detected on the unmodified hydrogels after immunohistochemical processing indicating only 
weak attachment of cells to hydrogels without cell adhesion moieties. Cytoskeletal organization 
can be seen by the arrangement of tropomyosin within the cells. Cell morphology for myoblasts 
was similar on both protein and peptide-modified hydrogels.  
a
 
b
 
c
 
Figure 4.2. Morphology and cytoskeletal architecture of skeletal myoblasts cultured on 
hydrogels modified with collagen I (a), laminin (b), or 0.5 mM RGD (c) after 24 hours of 
culture. Cytoskeletal architecture was assessed by immunostaining for tropomyosin, an 
intracellular contractile protein (red), and the nuclei were counterstained with DAPI (blue).  
 
4.3.2  Cardiomyocyte attachment and adhesion to peptide modified hydrogel films 
Neonatal rat cardiomyocytes were seeded onto the unmodified hydrogels, biologically-
modified hydrogels, and TCPS controls and cultured for 2 or 7 days. Brightfield microscopy 
revealed dramatic differences in the level of cellular attachment and morphology on the different 
substrates after 2 days of culture (Fig. 4.3). Cardiomyocytes on the surface of the protein-
modified hydrogels began to attach with evidence of cell spreading, which was similar to the 
cells cultured on gelatin-coated TCPS. However, cardiomyocytes seeded onto the RGD 
 61 
hydrogels maintained a rounded morphology with evidence of cell aggregation and little 
spreading.  There appeared to be more cells and larger cell aggregates on the hydrogel surfaces 
containing a higher concentration of RGD.  The unmodified hydrogels retained very few cells of 
which exhibited a rounded morphology. By seven days of culture, brightfield images revealed 
even fewer cells on the unmodified and RGD modified hydrogels (data not shown). On the 
protein-modified hydrogels, cardiomyocyte spreading was largely evident, but overall there were 
fewer cells present on the surface at day 7. 
 
a 
 
b 
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Figure 4.3. Brightfield microscopy of cardiomyocytes seeded onto gelatin-coated 
TCPS (a), unmodified hydrogels (b), and hydrogels modified with collagen I (c), 
laminin (d), 0.5 mM RGD (e) and 5 mM RGD (f) after two days in culture. 
 
 
Total DNA content was used as a quantitative measure for cardiomyocyte attachment 
(Fig 4.4). After two days in culture, all surfaces had significantly higher DNA levels compared to 
the unmodified hydrogel with the exception of laminin (p = 0.052). Additionally, total DNA 
content was significantly higher on the 5 mM RGD hydrogels compared to the gelatin-coated 
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TCPS controls. By day 7 of culture, total DNA content had dropped significantly for the 
collagen, 0.5 mM RGD and 5 mM RGD modified hydrogels when compared to day 2 values, 
and were similar to the levels reported for the gelatin-coated TCPS. Total DNA content was 
significantly higher for the protein and 5 mM RGD modified hydrogels compared to the 
unmodified hydrogels at day 7. In general, DNA quantification followed similar trends as those 
observed qualitatively through brightfield microscopy. 
 
 
 
 
Figure 4.4. Cell attachment was measured 
by total DNA content for cardiomyocytes 
cultured on gelatin-coated TCPS, 
unmodified hydrogels, and hydrogels 
modified with collagen, laminin, or RGD 
after 2 or 7 days of culture. * or # above a 
column indicates significance from TCPS 
control or unmodified hydrogel, 
respectively, on the same day; p < 0.05. 
 
 
Immunohistochemistry was performed to observe cardiomyocyte adhesion and 
cytoskeletal structure on the different substrates. Specifically, cardiomyocytes were stained for 
Troponin I, vinculin, and actin filaments (Fig. 4.5). The majority of the cells stained positive for 
Troponin I on the protein-modified hydrogels indicating that the cells adhered to these substrates 
were primarily cardiomyocytes. Troponin I staining also indicated good cellular adhesion and 
spreading of cardiomyocytes seeded on the protein-modified hydrogel surfaces. Furthermore, 
there was evidence of cross-striations indicative of a contractile apparatus. Organization of actin 
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filaments and presence of vinculin can be observed throughout the cells attached to the protein-
modified surfaces, demonstrating the formation of focal adhesion sites. Unmodified hydrogels 
had few cells remaining at the surface after processing for immunohistochemistry, and those 
cells present were arranged in small aggregates. No cells were present on the surface of the low-
concentration RGD hydrogels after processing, but cardiomyocytes on the surface of the high-
density RGD hydrogels exhibited rounded morphologies and were present in larger aggregates. 
Troponin I was detected in the cell aggregates found on the 5 mM RGD modified surface and the 
unmodified, but no organization of the cytoskeleton was observed. There was positive staining 
for vinculin within the cell aggregates present on the unmodified and RGD-modified hydrogels 
suggesting cell-cell contacts have formed. 
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Figure 4.5. Morphology and cytoskeletal architecture of cardiomyocytes cultured on gelatin-coated 
TCPS (a-d), unmodified hydrogels (e-h), and hydrogels modified with collagen I (i-l), laminin (m-p), 
or 5 mM RGD (q-t) after 7 days of culture. Immunostaining for Troponin I, an intracellular contractile 
protein (green) with the cell nuclei counterstained with DAPI (blue) was performed. Original 
magnification of the Troponin I images was 10x (a,e,i,m,q) or 20x (b,f,j,n,r). The 20x images were 
zoomed to enable visualization of cross-striations within the cells (c,g,k,o,s). In panels d,h,l,p and t, 
actin filaments were stained by phalloidin (green), focal adhesion sites were visualized through 
immunostaining for vinculin (red), and cell nuclei were counterstained with DAPI (blue) (d,h,l,p,t). 
Original magnification of vinculin images was 63x. 
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4.3.3  Gene expression of cardiomyocytes  
Gene expression for cardiomyocytes cultured on the different substrates was assessed by 
real time RT-PCR for !- and "- MHC, ANP and SERCA2a. The data are presented in Fig. 4.6. 
At day 2 post-seeding, cardiomyocytes on the unmodified hydrogels, 0.5 mM RGD or 5 mM 
RGD modified hydrogels, had significantly higher ratios of  !-/"-Myosin Heavy Chain (MHC) 
expression compared to the protein-modified hydrogels and to the gelatin-coated TCPS. Only 
cardiomyocytes adhered to the unmodified hydrogels showed significantly higher !-/"-MHC 
expressions at day 2 compared to the neonatal heart. By day 7, all surfaces yielded significantly 
lower ratios of !- to "-MHC expression when compared to the neonatal heart. Only 
cardiomyocytes adhered to TCPS or 0.5 mM RGD had significantly higher ratios than that of the 
unmodified hydrogel condition. 
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Figure 4.6. Gene expression of 
cardiomyocytes cultured on gelatin-coated 
TCPS, unmodified hydrogels, and hydrogels 
modified with collagen, laminin, or RGD 
after 2 or 7 days of culture. Genes associated 
with the fetal gene program were assessed 
for !-/ "-myosin heavy chain ratio (a), atrial 
natriuretic protein (ANP) (b), and 
sarco(endo)plasmic reticulum Ca
2+
 ATPase 
2a (SERCA2a). †,*,# above a column 
indicates significance from neonatal heart,  
TCPS,  or unmodified hydrogel, respectively, 
on the same day; p < 0.05. 
 
 
ANP expression was significantly higher for cardiomyocytes adhered to unmodified or 
collagen hydrogels compared to gelatin-coated TCPS or the 5 mM RGD hydrogel condition at 
day 2. All culture conditions, however, expressed significantly lower levels of ANP than the 
neonatal heart. By day 7, cardiomyocytes adhered to unmodified, collagen, and 5 mM RGD 
hydrogels had lower ANP expression compared to day 2. At day 7, laminin had significantly 
higher ANP expression compared to both the TCPS control and the unmodified hydrogel.  
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SERCA2a expression was significantly lower for all culture conditions with the 
exception of gelatin-coated TCPS, when compared to the neonatal heart at day 2. SERCA2a 
expression for cardiomyocytes cultured on laminin-modified hydrogels showed a 2.4-fold 
increase by day 7. SERCA2a expression for cardiomyocytes cultured on collagen-modified 
hydrogels increased similarly by 2.8-fold from day 2 to day 7, but was not statistically significant 
(p=0.07). In addition, no significant change in SERCA2a expression was seen on TCPS, 
unmodified hydrogels or the RGD-modified hydrogels from days 2 to 7. By day 7, SERCA2a 
expression for cardiomyocytes cultured on the TCPS and the unmodified hydrogels had dropped 
to significantly lower than the expression levels in the neonatal heart. 
 
4.4  Discussion 
 
Our findings demonstrate that whole proteins and the cell-adhesion oligopeptide, RGD, 
immobilized onto hydrogel substrates were not uniformly suitable for cardiomyocyte attachment, 
adhesion, and deposition of a contractile intracellular network. Furthermore, the robust skeletal 
myoblast cell line was found to be inadequate as a screening tool to identify suitable hydrogel 
substrates for primary cardiomyocyte attachment. Cardiomyocytes adhered preferentially to 
protein-modified hydrogels and began re-forming an organized, cross-striated network typical of 
native cardiomyocytes. A decrease in cell number was observed for the primary cardiomyocytes 
from days 2 to 7, which is likely due to the combined effects of the isolation procedure, which 
may damage a small fraction of the cells, and the fact that the cells do not proliferate. Although 
skeletal myoblasts adhered well to the peptide-modified hydrogels forming a contractile 
intracellular network, cardiomyocytes did not fully interact with the RGD tethers at the hydrogel 
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surface and appeared to self-associate into multi-layered cell aggregates. Higher concentrations 
of RGD (up to 20 mM) did not facilitate cardiomyocyte attachment to the hydrogel surfaces 
(unpublished findings). Overall, our findings indicate that full proteins are necessary to promote 
cardiomyocyte attachment and spreading while RGD is inadequate in providing the appropriate 
ECM cues for cardiomyocytes.  
Many cell lines and primary cells have been shown to attach well to RGD-modified 
polymers as seen here with skeletal myoblasts
33-35
. Cardiomyocytes have many different surface 
integrins which allow attachment to several ECM proteins, although their integrin expression is 
known to vary with cell development
36
. Cardiomyocytes have demonstrated good attachment to 
polymers modified with collagen
9
, laminin
37
, or fibronectin
19
. However, presentation of cell 
adhesive oligopeptides may not be sufficient to promote a normal myocytic phenotype 
representative of cell attachment to whole proteins. Boateng et al. 
38
 showed that neonatal rat 
cardiomyocytes were capable of adhering to oligopeptides, RDG and YIGSR (the synergistic cell 
adhesion site in laminin), when immobilized onto flexible silicone membranes. However, the 
authors noted that the cells lacked a myocytic morphology exhibiting few muscle striations and 
decreased levels of focal adhesion kinases when compared to membranes immobilized with 
laminin. In addition, Masters et al.
39
 demonstrated that primary valvular interstitial cells adhered 
well and proliferated on fibronectin-modified surfaces, but not on surfaces immobilized with 
RGD. Our findings are in agreement with these previous studies. We observed similar levels of 
cell attachment on the peptide modified hydrogels as the protein modified hydrogels, but cellular 
morphology and cell spreading were dramatically different, indicating an abnormal morphology 
on the RGD surfaces. It is possible that the synergistic cell adhesion sites, such as those found in 
fibronectin (i.e., RGD with the oligopeptide PHSRN) and laminin (i.e.,RGD with the 
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oligopeptide YIGSR), are necessary to promote cardiomyocyte attachment and to mimic cellular 
interactions with the full protein
40
. Although RGD is present in collagen type I and laminin, 
RGD is most widely known to interact with !5"1 integrins, while these proteins typically 
interact with different cell surface integrins
41
. 
Interestingly, the unmodified and RGD-modified hydrogel surfaces resulted in cellular 
aggregations at the surface. Cardiomyocytes are known to self-aggregate and form cardiac 
organoids when spatially guided
42-44
. In successfully engineered organoids, cardiomyocytes 
exhibit an elongated structure, gap junctions and contractile ability. However, the aggregates 
formed in this study exhibited little organization of troponin I and actin filaments with no 
observable cross-striations. Despite aggregation, the cardiomyocytes most likely could not form 
organoids due to lack of guidance of a 3D structure, relatively low cell densities, and the absence 
of supporting cell types.  
In addition to observing cardiomyocyte morphology, we further investigated differences 
in cellular response to modified hydrogels by exploring gene expression profiles for the 
cardiomyocytes. Cardiac hypertrophy can be associated with normal growth leading to increased 
cell size as the heart matures. However, pathological cardiac hypertrophy, which is associated 
with heart failure, results in a very different molecular composition within the cardiomyocytes. 
Pathological hypertrophy is often characterized by an induction of the fetal gene program
45,46
. 
From a tissue engineering perspective, cell-material interactions should promote healthy 
cardiomyocyte growth without activating pathological growth. Therefore, we chose to explore 
several genes which are part of the fetal gene program to assess whether the different ECM cues 
studied here influenced the molecular phenotype of the attached cardiomyocytes towards 
maturation associated with an adult phenotype, or towards maintenance of a fetal gene profile.  
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Myosin heavy chains (MHC) are the molecular motors of muscle and exist as two 
isoforms, !-MHC and "-MHC. The ratio of these critical contractile proteins changes rapidly as 
the fetal heart matures. During heart development in the rat fetus, "-MHC is the predominant 
ventricular MHC, but after birth "-MHC is largely replaced by !-MHC in the normal heart. It 
has been established that when adult rat hearts undergo pathological hypertrophy, this process 
reverses with the re-expression of "-MHC as the predominant MHC.  Our findings did not 
indicate a steady pattern of maturation of cardiomyocytes when cultured on the hydrogel 
substrates. The hydrogel conditions which did not support good cardiomyocyte adhesion 
(unmodified and RGD-modified) exhibited a high !/"-MHC expression ratio, characteristic of 
maturing cardiomyocytes, after 2 days. Interestingly, these ratios were significantly higher than 
the ratios for the protein modified hydrogels and the TCPS control. It is possible that cell 
aggregation observed on the unmodified and RGD hydrogel surfaces initially aided in a normal 
phenotype. Khait et al. observed increased !/"-MHC expression in a contractile bioengineered  
heart muscle tissue formed from neonatal rat ventricular myocytes over a ten day period
47
. In 
contrast, the cell aggregates present on unmodified and RGD-modified hydrogels lacked 
organization, and by day 7 the !/"-MHC expression ratio had dropped. The !/"-MHC 
expression ratio had significantly dropped for all conditions by day 7.  
The cardiomyocytes cultured on collagen and laminin hydrogel surfaces appeared to be 
developing a normal cytoarchitecture even though they exhibited a decrease in !/"-MHC 
expression. When cardiomyocytes are isolated and cultured in a new environment they must re-
establish their contractile apparatus. "-MHC is known to be an important protein in the 
developing heart associated with forming the cyotarchitecture of the cells. In addition, a recent 
hypothesis was put forth that cardiomyocytes may re-enter the fetal gene expression program as 
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a positive mechanism for surviving stress, rather than entrance into a diseased state only, but this 
hypothesis has not been confirmed 
48
. Another study suggested that !-MHC expression increases 
in response to fibrosis in the adult heart, potentially suggesting a regulatory mechanism 
involving cardiomyocyte interaction with interstitial proteins
49
. Therefore, decreased "/!-MHC 
expression may not be a good indicator of pathological growth, at least at these early culture 
times, for cardiomyocytes adapting to biomaterials from their native environment.  
In addition, we examined gene expressions for ANP and SERCA2a, which are also part 
of the fetal gene program. Along with the myosin heavy chains, these genes have traditionally 
been used as markers for both cell maturation and hypertrophy. ANP is produced in the fetal 
heart, but shortly after birth its production is reduced and restricted to the atria. As a result, 
decreasing ANP expression is observed as cardiomyocytes mature, but is known to rise again 
during hypertrophy
50
. Recently, ANP was used as a marker to determine the maturational state of 
cardiomyocytes attached to an electrospun polyurethane scaffold, where cells with the most 
organized cytoskeletal structure expressed the lowest levels of ANP
14
. Our findings showed a 
similar sharp decrease in ANP expression for all substrates within 2 days of culture when 
compared to expression levels in the neonatal heart. By 7 days, expression had decreased even 
further. Unlike the results of the "/!-MHC ratio, the ANP expression of cardiomyocytes seemed 
to follow a more normal path of maturation. In general, cardiomyocyte attachment and adhesion 
were similar on both collagen-and laminin-modified hydrogels. However, at day 2, expression 
for ANP was significantly higher on the collagen-modified hydrogels compared to the laminin-
modified hydrogels, suggesting a difference in cardiomyocyte molecular phenotype for the 
different proteins. By day 7, ANP expression levels were similar among all protein- or peptide-
modified hydrogels.    
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SERCA2a is a modulator of calcium in cardiac muscle cells, and its expression rises 
during cardiomyocyte maturation to provide for better contractile function of the maturing cell. 
However, SERCA2a expression also reverses and clear down-regulation is observed during 
hypertrophy. Results of the SERCA2a study also showed some signs of cardiomyocyte 
maturation. There was an initial decrease in SERCA2a expression from the neonatal heart at day 
2 post-seeding for all substrates. However, by day 7, there was a marked increase in the 
expression of SERCA2a in cardiomyocytes adhered to protein-modified hydrogels compared to 
the neonatal heart, which was not observed on the other substrates. These findings suggest that 
the protein-modified hydrogels offer a superior culture environment for enhanced SERCA2a 
expression and potentially for enhancing contractile properties, although additional studies are 
necessary.  
In summary, neonatal cardiomyocytes exhibited abnormal myocytic morphologies on 
RGD-modified hydrogel surfaces resulting in cell aggregation, but readily spread on protein-
modified hydrogel surfaces. The use of a skeletal myoblast cell line confirmed that the RGD-
modified hydrogel surfaces were biologically active, but were not predictive of cardiomyocyte 
behavior.  Interestingly, cardiomyocyte aggregation appears to have had some positive effects 
with respect to increased ratios of !/"-MHC expression, although SERCA2a was markedly 
lower when comparing expression levels of cardiomyocytes cultured on protein-modified 
substrates.  Overall, modification of hydrogels with collagen I or laminin resulted in superior 
cardiomyocyte attachment, morphology, and development of a contractile cytoarchitecture with 
decreased ANP expression and increased SERCA2a expression. Our findings suggest that whole 
proteins are more effective for promoting cardiomyocyte interaction with hydrogel surfaces, 
especially when compared to RGD. Our results will aid in selecting appropriate biochemical cues 
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for enhancing cardiomyocyte attachment and phenotype to 3D scaffolds towards engineering the 
myocardium. 
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Chapter 5 
 
Ultrastiff hydrogel substrates affect cardiomyocyte gene expression 
 
5.1 Introduction 
 
 Mechanical signals are important regulators for many cell types, impacting cellular fate 
and overall function. One mechanism by which cells receive mechanical signals from their 
extracellular environment is through sensing their underlying substrate
1,2
. A number of studies 
have recently shown that the stiffness of the substrate to which cells are attached can 
dramatically impact the differentiation fate of stem cells
3,4
, the proliferation or spreading of 
fibroblasts
5,6
, endothelial cells
7
, and smooth muscle cells
8,9
, and the contractile function of 
muscle cells
10,11
. This body of literature strongly suggests that substrate stiffness should be 
carefully selected when designing biomaterial scaffolds for tissue engineering, or when selecting 
substrates used as platforms for basic research.  
 In particular, cardiomyocytes, the beating cells of the heart, have been cultured on a wide 
range of substrates that support cardiomyocyte survival, but which possess very different 
properties and span over ~six orders of magnitude in stiffness. While the native rat heart has a 
modulus of ~10-20 kPa
12
, substantially stiffer substrates have been employed to study rat derived 
cardiomyocytes in vitro and in tissue engineering strategies. For example, tissue culture 
polystyrene, which has a modulus of ~1 GPa
13
, is commonly used in basic cardiomyocyte 
biology research
14
. While cell-scaffold systems for cardiac muscle tissue engineering should 
closely mimic the properties of the native heart, significantly stiffer substrates have been 
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successfully employed as cardiac patches in rat infarct models showing improved contractility
15
, 
and may be required from a handling and implantation perspective. Other substrates range from 
synthetic hydrogels of moderate stiffness (~50-2000 kPa)
16-18
 to very soft protein gels (~1-200 
kPa)
19-21
. The wide range of platforms on which cardiomyocytes are cultured are likely to 
produce dramatic differences in cellular function, making it difficult to compare cell response 
across studies. 
 Several studies have recently investigated cardiomyocyte function in response to a range 
of substrate stiffness, which span the stiffness of a healthy heart to a diseased heart. For example, 
cardiomyocytes cultured on polyacrylamide substrates attached and spread on substrates with 
stiffness ranging from 1 to 43 kPa, but substrates stiffnesses of 11-17 kPa produced the most 
striated sarcomeres
11
. Similar findings were observed in a polyacrylamide-collagen I system for 
neonatal rat ventricular myocytes, which yielded the most aligned striations on 10 kPa (vs 1 or 
50 kPa) gels
10
, while a separate study produced the most aligned striation on 22 and 50 kPa (vs 3 
or 144 kPa) gels
22
. Differences in contractile function have also been recorded as a function of 
substrate stiffness. For example, a larger fraction of the cardiomyocyte population beat at 1 Hz, 
and beat for longer on 1 or 11-17 kPa materials when compared to 34 kPa stiff substrates
11
.  Gels 
with a modulus of 10 kPa promoted maximal contraction force of cardiomyocytes that beat on 
the surface, compared to lower stiffness substrates (i.e., 1 or 5 kPa), or higher stiffness substrates 
(i.e., 25 or 50 kPa)
10
. In a separate study, a larger voltage was needed to stimulate rat 
cardiomyocytes as hydrogel stiffness increased from 3 to 50 kPa
22
. In addition to striation and 
contraction, the substrate stiffness has also been shown to affect gene expression of 
cardiomyocytes. The gene expression of a protein that regulates calcium transport in 
cardiomyoyctes, SERCA2a, was highest in cardiomyocytes cultured on substrates with a 
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stiffness of 10 kPa, during a study where substrate stiffness spanned 1-50 kPa
10
. Together, these 
findings suggest that on relatively soft substrates, ranging from ~1 to 50 kPa, cardiomyocytes 
function optimally on stiffnesses that more closely mimic the native myocardium. 
Within rat hearts that have experienced an infarct, the infarct tissue has a stiffness of ~50 
kPa
12
.  Cardiomyocytes exposed to this higher stiffness due to an increased load on the heart are 
known to change their gene expression patterns of atrial natriuretic protein (ANP), brain 
natriuretic protein (BNP), SERCA2a and the ratio of alpha to beta isoforms of myosin heavy 
chain (MHC) toward those observed in fetal cardiomyocytes. It is hypothesized that this 
difference of gene expression is regulated through both metabolic and mechanical pathways
23
, 
although the exact regulatory mechanism is still unknown and may change depending on the 
cell’s environment. Because these gene expression profiles change dramatically upon entrance 
into the disease state
24
, they provide a good indication of the state of the cell, i.e. healthy versus 
pathological. Recently, our group has shown that cardiomyocytes adhered to different protein or 
peptide-modified biomaterial scaffolds, with moduli in the range of ~300 - 2000 kPa, led to 
changes in ANP, SERCA2a and !-/"-MHC gene expression within cardiomyocytes over time17. 
Additionally, ANP expression levels within cardiomyocytes have been shown to change when 
these cells were seeded on aligned versus randomly oriented nanospun networks
25
. These 
findings suggest that the phenotype of cardiomyocytes changes as the cells adjust to their new 
environment, and this change is dependent on the biomaterial. This is evidenced by changes in 
the cardiomyocyte gene expression of a series of genes, which are known to respond to changes 
in heart stiffness in vivo. 
 The objective for the present study was to investigate whether cardiomyocytes isolated 
from neonatal rat ventricles would alter their gene expression profiles towards maturation, or 
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pathological response, when cultured on ultra stiff substrates. A poly(2-hydroxyethyl 
methacrylate) (pHEMA) hydrogel substrate was chosen because the crosslinking density, which 
largely dictates the mechanical properties, can readily be tuned through simple changes in the 
crosslinker concentration, while maintaining a similar hydrogel chemistry and independently 
immobilizing proteins on the hydrogel surface to promote cellular attachment. Cardiomyocyte 
response to changes in hydrogel stiffness was evaluated through cytoskeletal arrangement of 
proteins and the expression of genes that are known to change during maturation: the ratio of !- 
to "-myosin heavy chain (MHC), atrial natriuretic protein (ANP), brain natriuretic protein (BNP) 
and sarco(endo)plasmic reticulum Ca
2+
ATPase (SERCA2a). 
 
5.2  Materials and methods 
 
5.2.1  Fabrication of hydrogel films with varied crosslinking density 
A solution of 80% (v/v) 2-hydroxyethyl methacrylate (HEMA) (Polysciences, Inc), either 
0.1, 0.02 or 0.00002 (mol: 1 mol HEMA) tetraethylene glycol dimethacrylate (TEGDMA) 
crosslinker (Polysciences, Inc), and 1.5% (w/w) 2, 2-dimethoxy-1,2-diphenylethan-1-one 
(Irgacure 651, Ciba Specialty Chemicals) was mixed in a 59% water: 41% ethylene glycol 
solution. The solution was poured between two glass slides spaced 0.8 mm apart, coated with a 
thin layer of glycerol to prevent the hydrogel from adhering to the glass surface. The solution 
was polymerized under 320-500 nm UV light (5 mW/cm
2
) for 6 min. The hydrogel sheet was 
soaked in 50% methanol overnight with one solution change, followed by 70% ethanol with 
three solution changes to remove unreacted polymerization products and sterilize, then soaked in 
a DI water bath for a minimum of 24 hours. Individual 5 mm discs were punched from the 
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hydrogel sheet, and dried under high vacuum for 2 h. The free hydroxyl groups within each 
HEMA repeat unit were reacted with 100 mM CDI in dry acetone, as described previously
26
. 
Collagen type I (rat tail, Invitrogen, 5 mg/ml) was diluted in sterile sodium bicarbonate buffer 
(pH = 10.4) to a concentration of 667 µg/ml. Protein was conjugated to discs by slow rotation of 
the discs in the protein solution at 4°C for 48 h. Alternatively, 85 µl of the HEMA precursor 
solutions were polymerized in cylindrical molds (5 mm height, 5 mm diameter), soaked in 70% 
ethanol with three solution changes, then maintained in water at least 24 hr to equilibrate for 
mechanical testing. 
 
5.2.2  Equilibrium swelling 
  Equilibrium swelling ratios were determined from hydrogels fabricated as described 
above, both with and without collagen I conjugation at the surface.  Hydrogels were equilibrated 
for a minimum of 24 h at room temperature. The swollen discs were weighed (ms) (n=6), 
lyophilized for 48 hr, and weighed again to obtain the dry weight (md). The equilibrium mass 
swelling ratio (q = ms/md) was calculated and then converted to an equilibrium volumetric 
swelling ratio (Q) using known densities of the uncrosslinked polymer and solvent. The Flory-
Rehner equation
27
 was used to estimate the average molecular weight between cross-links, 
! 
M
c
, 
using the specific volume of polymer, 
! 
" , the molar volume of the solvent, V1,  !  as previously 
described for crosslinked pHEMA systems
28
, and the equilibrium polymer volume fraction "2,s. 
The predicted modulus of each hydrogel, based on crosslinking density, was determined using 
the rubber elasticity theory
29
, where a poisson’s ratio of 0.3
30
 was used for the pHEMA system. 
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5.2.3  Analysis of the collagen I layer at hydrogel surface 
 Hydrogel samples of each condition (n = 2) were analyzed while hydrated using a 
VASE! ellipsometer (J.A. Woolam) with an HS-190 monochromator (J.A. Woolam), to 
determine the average thickness of the surface collagen I layer. 
 
5.2.4  Mechanical testing of compressive modulus 
 Cylindrical hydrogel samples with a height to diameter ratio of ~1 were compressed 
while hydrated between two platens, at a rate of 0.15 / min to 40% of the total height (or to 
maximum deformation) on a BOSE mechanical tester. The linear region of the force vs 
displacement curve was used to calculate the compressive modulus. 
 
5.2.5  Cardiomyocyte isolation and seeding of scaffolds 
Hearts were isolated from 1-3 day old Sprague-Dawley rat pups (Charles River 
Laboratories) according to a protocol approved by the University of Colorado’s Animal Care and 
Use Committee. Heart tissue was washed in a heparin solution containing 99% calcium and 
bicarbonate free HEPES-buffered Hanks (CBFHH) and 1% heparin stock (10,000 USP units/ml). 
Each heart was minced into 12-16 pieces and placed in a 1.5 mg/ml trypsin solution (Difco, 
215240) in CBFHH with 0.2% v/v penicillin/streptomycin (Gibco, 15070) and DNase (Sigma, 
D8764).  Cells were isolated from tissue in a conical tube with a flea stir bar during 12 digestion 
intervals with alternating pipetting and spin stages. After separating from the tissue, the trypsin 
cell suspension was neutralized with calf serum (Sigma, C8056) and centrifuged.  A 45 min pre-
plating step enriched the culture for cardiomyocytes. Cells were again centrifuged, and the cell 
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pellet was resuspended in MEM growth medium (Gibco, 11575-032) with 5% calf serum 
(Hyclone), 50 U/ml penicillin-G, 1.5 µM vitamin B12, and 0.1 mM Bromodeoxyuridine (BrdU). 
Hydrogel scaffolds were pre-soaked in MEM medium with no additives for 2 hours prior 
to seeding. Cardiomyocytes were seeded either onto scaffolds of modified stiffness, or directly 
(in the case of controls) in wells of a 48-well plate at a density of 45,000 cells/cm
2
. After 24 h in 
culture, medium was exchanged for serum-free medium (MEM, 0.1% (w/w) bovine serum 
albumin (BSA), transferrin, selenium, and 0.1 mM BrdU), and was changed every 48 hours 
thereafter. 
 
5.2.6 Real-time RT-PCR  
Rat hearts were immediately frozen in liquid nitrogen, then combined with Tri Reagent! 
(Sigma), homogenized, and stored at -80°C. The manufacturer’s instructions were followed to 
isolate RNA from the cells. A High-Capacity cDNA Reverse Transcription Kit (Applied 
Biosystems) was used to sythesize cDNA from the heart RNA. Cardiomyocytes cultured in 
TCPS control wells, or on hydrogels, were treated according to the manufacturer’s instructions 
with a Fast SYBR Green Cells-to-CT kit for RNA isolation and cDNA synthesis (Applied 
Biosystems). Forward and reverse primers developed for the fetal gene program
14
 were used: 
18S (housekeeping gene), "-Myosin Heavy Chain, #-Myosin Heavy Chain, atrial natriuretic 
protein (ANP), brain natriuretic protein (BNP) and sarco(endo)plasmic reticulum Ca
2+
 ATPase 
(SERCA2a). Samples were run on ABI Fast7500, in 9600 Emulation mode, and analyzed by 
relative expression of the gene of interest to the housekeeping gene (n = 9). The relative 
expression of each gene was normalized to the average expression of that gene in cells on the 
most compliant hydrogel (350 kpa) at 16 h, to compare expression levels between studies. 
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5.2.7 Immunohistochemistry 
Hydrogel discs were removed from culture medium, rinsed briefly in a CBFHH solution, 
fixed in a 4% paraformaldehyde solution for 20 min, then stored in CBFHH at 4°C. Prior to 
antibody application, hydrogels were incubated in a 0.5% Triton-X solution for 10 min, then 
placed in a blocking solution of 10% goat serum, 3% BSA, and 0.25% Triton-X in PBS for 60 
min at room temperature. An anti-!-actinin primary antibody (Sigma-Aldrich, A5044) was 
applied to the hydrogel surface at 1:200 and incubated overnight at 4°C. The hydrogels were 
rinsed three times in blocking solution, before application of the Alexafluor goat 546 anti-mouse 
(Invitrogen, A11030) secondary antibody (1:400) for one hour at room temperature. Following 
three additional rinses in PBS, cell nuclei were stained with DAPI 1:1000 (Invitrogen, D1306) 
and imaged hydrated under 10x and 63x using confocal microscopy (Zeiss LSM5 Pascal). 
 
5.2.8 Statistical analysis 
Samples were compared using a two-sample T-test assuming unequal variance. The 
effect of time and substrate stiffness on gene expression was analyzed using ANOVA. Values 
were reported as the mean ± standard error of the mean. A value of p < 0.05 was considered 
statistically significant. 
 
5.3 Results 
 
Analysis of the compressive modulus of pHEMA hydrogels fabricated from a range of 
crosslinker concentrations yielded three average modulus values of 350, 2000, and 4800 kPa 
(Fig. 5.1a). All averages were statistically significant from each other (p < 0.0001). The 
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crosslinking density, which plays a large role in determining water content and mechanical 
properties of hydrogels, was estimated through experimental measurements of equilibrium 
swelling ratios. The volumetric swelling ratio (Q) and the average molecular weight between 
cross-links, 
! 
M
c
, are given in Table 5.1 for pHEMA hydrogels, with and without conjugation of 
collagen I at the surface. As expected, as 
! 
M
c
 increased, the swelling ratio increased. The 
modulus was predicted from the rubber elasticity theory from crosslinking density and compared 
to the experimentally measured modulus of each hydrogel formulation (Fig. 5.1b). The predicted 
modulus values for all pHEMA hydrogels were within 30% of the measured modulus values for 
each formulation (Table 5.1). The pHEMA hydrogels that had been reacted with collagen more 
closely fit the experimental moduli than those with no collagen. 
 
a.  b.  
Figure 5.1.  The compressive modulus of pHEMA scaffolds decreased as the crosslinker 
(TEGDMA) decreased (a). The measured modulus values of pHEMA hydrogels closely followed 
predicted modulus values based on the concentration of TEGDMA crosslinker (b). * indicates 
statistical significance (p ! 0.05). 
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Table 5.1. Predicted and measured p(HEMA) hydrogel compressive properties 
Crosslinking 
Ratio              
(mol 
TEGDMA: 
mol HEMA) 
Experimentally 
Determined 
Compressive 
Modulus (kPa) 
Volumetric 
Swelling 
Ratio (Q) 
Average 
Molecular 
Weight 
between 
Crosslinks 
(Mc) 
Predicted 
Modulus 
(kPa)
a
 
Volumetric 
Swelling 
Ratio (Q)
b
 
Average 
Molecular 
Weight 
between 
Crosslinks 
(Mc)
b
 
Predicted 
Modulus 
(kPa)
a,b
 
0.10000 
4800 ± 700 1.51 ± 0.03 600 ± 200 
10,000 ± 
2300 
1.60 ± 0.05 1300 ± 600 
4800 ± 
1600 
0.02000 
2000 ± 105 1.69 ± 0.00 2600 ± 120 2100 ± 100 1.72 ± 0.02 3400 ± 700 1700 ± 300 
0.00002 
350 ± 25 1.85 ± 0.01 
14000 ± 
1000 
380 ± 30 1.87 ± 0.02 
19000 ± 
4900 
300 ± 70 
        
a
 calculated from the rubber elasticity theory 
b
 collagen-functionalized surface 
 
To promote cardiomyocyte attachment, collagen type I was immobilized on the surface 
of each of the pHEMA hydrogels. The thickness of the collagen I layer at the surface of the 
pHEMA discs was evaluated through ellipsometry and determined to be ~20-25 nm (Table 5.2), 
indicative of a monolayer of collagen on the surface of the hydrogels.  
 
Table 5.2. Collagen I thickness on pHEMA substrates 
Crosslinker: Monomer Ratio              
(mol TEGDMA: mol HEMA) 
Collagen I layer 
thickness (nm) 
0.10000 22 ± 7 
0.02000 23 ± 3 
0.00002 23 ± 6 
 
 
After 16 and 168 hours in culture, cardiomyocytes cultured on each of the hydrogel 
substrates were qualitatively assessed through morphology and cytoskeletal structure of !"
actinin. Nearly all cells stained positive for !"actinin, indicative of cardiomoyctes!with little 
evidence of non-myocyte cells on the different hydrogel substrates. In general, cardiomyocytes 
attached and were spreading on all three substrates by 16 h. With longer culture times, increased 
cell spreading was observed by 168 h on all three substrates. Fewer cells appeared to adhere to 
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the most compliant (350 kPa) pHEMA surfaces at both early (16 h) and late (168 h) timepoints, 
and the cells present appeared to have fewer focal adhesions with the surface of the hydrogel 
(Fig. 5.2), as evidenced by the number of visible articulation sites of each cell with the hydrogel 
surface. After 7 days in culture, the cells had not formed a mature contractile network, and 
showed minimal evidence of striation.  
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Figure 5.2. Cardiomyocyte cytoskeletal structure as seen through 
detection of !-actinin (red), and nuclei (blue), adhered to pHEMA 
surfaces with varied stiffnesses of 4800 kPa (a,d,g,j), 2000 kPa (b,e,h,k) 
and 350 kPa (c,f,i,l). Images were taken with 10x (first row, third row) 
and 63x (second row, fourth row) magnification, after 16 h (first row, 
second row) and 168 h (third row, fourth row) in culture. 
 
 
The effects of substrate stiffness on cardiomyocyte gene expression were evaluated over 
the course of one week. Cardiomyocyte RNA was collected from two separate isolations and the 
gene expression associated with the most compliant hydrogel, 350 kPa, at 16 h in culture was 
used as the internal control to account for any inherent differences between the two isolations 
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and studies. The gene expression ratio of !- to "-Myosin Heavy Chain (MHC) isoforms, which 
increases in the developing rat heart, was examined within the cardiomyocytes adhered to 
scaffolds of different stiffness (Fig. 5.3a). Time was a significant factor for all three stiffness 
conditions. Although the expression ratio initially rose until 72 h, it again dropped for all 
conditions after one week (168 h) in culture. The expression of ANP, a hormonal signaling 
molecule whose expression decreases over time in the developing rat heart, showed no 
significant changes in expression over time, nor did it vary by substrate stiffness (Fig. 5.3b). In 
contrast, BNP, another hormonal signaling molecule that is known to decrease in the maturing 
heart, showed some dependence in expression on time and stiffness (Fig. 5.3c). After 24 h, an 
increase in expression was observed with an increase in hydrogel stiffness. Time was also a 
significant factor for the least and most compliant hydrogels. The gene expression profile of 
SERCA2a was also examined during this study (Fig. 5.3d). Although no overall trends indicating 
dependence on time or hydrogel stiffness were observed, SERCA2a expression was significantly 
higher after 168 h in culture than after 16 h, for both the 350 kPa (p = 0.036), and the 2000 kPa 
(p = 0.017) surfaces. However, on the stiffest substrate (4800 kPa), no significant change in 
SERCA2a occurred over the course of the study. 
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Figure 5.3. Normalized expression of a) !-/"-MHC ratio, b) ANP, c) BNP and d) SERCA2a in 
cardiomyocytes cultured on pHEMA hydrogel surfaces of different stiffness. * indicates 
statistical significance (p# 0.05) 
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5.4  Discussion 
 
 This study utilized pHEMA hydrogel scaffolds of three different stiffnesses, and surface 
attachment of collagen I, as a platform to explore changes in cardiomyocyte gene expression and 
cytoskeletal network on ultrastiff substrates. The gene expression profile of cardiomyocytes 
during the course of this study did not indicate maturation, nor did it indicate development into a 
disease state, when cultured on the hydrogel surfaces. Unlike the defined maturation of neonatal 
cardiomyocytes, or the entry into a disease state, there were not clear changes in expression for 
each gene. Instead, some changes were observed for the expression of myosin heavy chains and 
BNP, but no changes were observed for ANP or SERCA2a based upon time or stiffness. The 
cytoskeletal network was observed through !-actinin, but striation was not observed for the 
tested stiffness conditions or time points. These results suggest that cardiomyocytes can sense 
and respond to changes in ultrastiff substrates, but do not respond with defined gene expression 
profiles indicating maturation nor disease. 
 The pHEMA hydrogel system chosen for this study has many advantages, but also has 
several limitations. This system was chosen since the stiffness could be varied through a change 
only in the crosslinking agent concentration added to the monomer solution. Another advantage 
of pHEMA was the high density of hydroxyl groups used to conjugate collagen I at the hydrogel 
surface, and their controlled incorporation into the polymer. For all precursor solutions, the 
amount of HEMA remained the same. As a result, the surface of each polymerized hydrogel 
condition was controlled for the number of hydroxyl groups, the functional part of the HEMA 
monomer that was used to conjugate collagen. 
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In contrast to pHEMA, other hydrogel systems, such as polyacrylamide, have been well-
established for use in studies of cell response to substrate stiffness
2
 due to their low, tissue-like 
modulus. Although pHEMA hydrogels can be fabricated to span a wide range of stiffness, they 
have limitations in reaching very low moduli. The initial crosslinker concentration in the 
monomer solution could likely be lowered below 0.00002 mol: mol HEMA and still allow the 
solution to crosslink; however, due to chain entanglement, even extremely low crosslinking 
densities within the pHEMA system may not swell with enough water to substantially decrease 
the modulus. In addition, densely arranged HEMA side chains have some hydrophobic 
interactions, minimizing the amount they will swell
31
. Instead, possible methods for lowering the 
modulus would be to include a longer hydrophilic crosslinking agent, or to copolymerize more 
hydrophilic monomers with HEMA to enhance the overall hydrophilicity, and hence swelling, 
thus lowering the effective crosslinking density. 
The experimentally determined moduli and theoretical moduli of the hydrogels based 
upon crosslinking density were very similar. These results indicate that experimental swelling 
results of the polymer and estimates for pHEMA mechanical properties were very accurate in the 
crosslinked hydrogel model that was analyzed. This system therefore allows prediction of a 
desired pHEMA stiffness based upon the crosslinking density. The equilibrium swelling ratios of 
collagen and non-collagen containing pHEMA hydrogels were performed to determine whether 
the CDI reaction during the attachment of collagen would affect the swelling behavior of the 
polymer. However, the CDI reaction appeared to have little effect for the two most compliant 
hydrogel conditions. Although the predicted modulus is higher in the non-collagen hydrogels 
than the collagen-reacted hydrogels based upon the crosslinking density, the reasons for this 
discrepancy are unknown. It is possible the results of the swelling study had some error, resulting 
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in a higher apparent crosslinking density, or that measurement of the compressive modulus had 
error. Although the measured modulus of the 4800 kPa hydrogel was very close to the predicted 
modulus of the collagen-reacted 4800 kPa hydrogel, it was also possible the addition of collagen 
affected the swelling behavior of the hydrogel, leading to a reduced modulus as compared to the 
actual value. 
Characterization of the collagen I layer at the surface of the hydrogels indicated a very 
similar thickness of ~ 20 nm between samples. This thickness is indicative of a collagen layer in 
the range of one collagen molecule deep. Although the thickness was determined for all hydrogel 
stiffnesses, ellipsometry only detected changes in refractive index between the collagen layer and 
the hydrogel. Therefore, surface patterns of the collagen (fibrillar vs non) and density of the 
collagen layer could not be accurately analyzed through this method. Although each hydrogel 
has a collagen monolayer at the surface, the cells may not interact with exactly the same protein 
coating on hydrogels of each stiffness. Further analysis would be necessary to more precisely 
characterize the changes between collagen layers on each hydrogel condition. 
After completion of hydrogel characterization, the gene expression of cardiomyocytes on 
each of the surfaces was explored. The specific set of genes from the fetal gene program were 
chosen for their well-defined expression patterns in the fetal, mature and diseased state
24
. 
Generally, changes in expression are dramatic, often with a several-fold change within days, and 
therefore reveal cell response to their environment. In the maturing rat heart, the ratio of alpha to 
beta MHC is expected to increase over time as the heart shifts from sustaining itself to 
contracting more vigorously. This is an important mechanism through which cardiomyocytes 
maintain an appropriate contractile force for their environment
23
. In the present study, the 
increase in the !-/"-MHC ratio after 72 h of culture, then subsequent drop by 168 h in culture on 
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scaffolds of all stiffnesses, indicates cardiomyocytes begin to express genes for MHC isoforms in 
a ratio more characteristic of maturing myocytes, but are not able to maintain this process over 
time within this range of stiffness. These findings may indicate that initially, cardiomyocytes 
attached to the surface put more energy into developing their contractile function, but cannot 
maintain these efforts over time on ultrastiff substrates. The inability of the cardiomyocytes to 
develop cytoskeletal striation on these surfaces also indicates limited progress towards 
maturation of the contractile apparatus on the hydrogels. These changes may be due to the larger 
resistance they encounter from these relatively stiff substrates. Other work has indicated that stiff 
substrates cause fatigue in cardiomyocytes since they constantly work against too large a 
resistance, ultimately leading to reduced contractile function
10,11
. This functional compromise 
has been observed after cardiomyocyte attachment to substrates with a modulus as low as (~30 
kPa)
11
. However, on the ultrastiff pHEMA substrates used in the present study, a higher ratio of 
!-/"-MHC remained on the least stiff substrates after 168 h in culture, compared to the stiffest 
substrate, which had the lowest ratio. This supports the hypothesis that increased resistance 
decreases cell function over time, but also indicates that cells are still responsive to changes in 
stiffness amongst much stiffer substrates than those in a tissue-like (~1-50 kPa) range. The cells 
in the present study did not cease function upon reaching a specific threshold, nor did they 
respond with identical gene expression profiles on the varied ultrastiff scaffolds. 
In addition to examining changes in the myosin heavy chain ratio, the expression of both 
ANP and BNP hormones was examined. In a healthy heart, the production of these signaling 
molecules is lower in adult ventricles than in fetal ventricles
32
. Furthermore, these proteins are 
governed in part by mechanoreceptors that detect changes in the heart, such as dilation and wall 
tension, during disease
33,34
. As such, we hypothesized that these genes would be sensitive to 
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changes in substrate stiffness due to the cell’s ability to mechanically sense the environment. 
Over the course of this study, ANP and BNP expression did not follow the same trends. 
Interestingly, ANP expression did not vary due to time or stiffness, but BNP depended on both 
factors. The most compliant hydrogel surface appeared to have the greatest effect on BNP 
expression, where 168 h culture time produced elevated expression levels. This elevated 
expression profile is characteristic of a fetal state, or entry into a disease state, but not of 
maturation towards adult myocytic phenotype. After 24 h of culture, however, lower expression 
levels were observed on the more compliant substrates, indicating they promote expression 
patterns more indicative of maturation than the 4800 kPa surface. In vivo, the transition from 
healthy tissue to diseased tissue leads to an increase in ANP and BNP expression in 
cardiomyocytes. The same could be expected during this study, since the cells are cultured on 
stiff substrates. However, neither of the natriuretic proteins fluctuated dramatically during the 
week-long study, as is often seen when cardiomyocytes enter disease states. 
 Although mechanotransduction is hypothesized to play a role in ANP expression
33
, the 
amount of resistance a cardiomyocyte needs to experience for resulting changes in gene 
expression are unknown. However, some communication with the cardiomyocyte and the 
environment is likely occurring since the BNP expression changes over time within cells 
cultured on the 350 and 4800 kPa hydrogels. These differences may be due to changes in the 
substrate stiffness between the soft heart and the much stiffer hydrogel. However, they may also 
be due to factors such as the type and quantity of cell attachment moieties to the extracellular 
matrix, or the lack of 3D arrangement of myocyte cultures. 
Opposite the natriuretic proteins, SERCA2a is upregulated as healthy cardiomyocytes 
mature because it is plays a role in calcium transport within the cell. As the cell grows and 
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develops, fluctuations in calcium concentration must occur more quickly. During this study, the 
stiffness of the scaffold did not impact SERCA2a expression. Over time, all scaffold stiffnesses 
promoted SERCA2a upregulation, which is also expected in healthy, maturing tissue, indicating 
the cells are conditioning for quicker, more powerful contraction. However, expression of 
SERCA2a appears independent of substrate stiffness over the 300-4800 kPa range studied 
herein.  
 It was expected that the genes examined throughout this study would increase or decrease 
several-fold, both because cardiomyocyte expression changes the most dramatically as cells exit 
the fetal state and become mature, and because the range of substrate stiffness used in this study 
varied from moderately soft to extremely stiff. However, even though a large stiffness range was 
attained, hydrogels did not have a modulus comparable to the range of the native heart (~10-70 
kPa)
12,16,35
. After observing the relatively small changes in gene expression produced from the 
large changes in stiffness, it appears different mechanisms within the cell may be acting to 
regulate expression in very soft (heart-like) substrates vs. very stiff substrates. A sliding-scale 
response did not appear, where cells on the 350 kPa stiffness reacted more like maturing heart 
cells in vivo than those on 4800 kPa hydrogels. Instead, undefined gene profiles were observed 
on these ultrastiff materials. Importantly, however, the cardiomyocytes did respond to changes in 
stiffness through changes in gene expression. 
 As a heart model, the wide range of stiffness in this system falls between the measured 
stiffness values of rat heart muscle and the tissue-culture polystyrene system that is commonly 
used in 2D studies. However, this study highlights the important finding that cardiomyocytes can 
respond to changes in substrate stiffness on ultrastiff materials. The results of this work 
characterize one aspect of the cell response in the gene expression of cardiomyocytes that result 
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from changes in stiffness. Culture of cardiomyocytes on ultrastiff substrates did not appear to 
lead towards maturation, however it also did not indicate entry into a disease state. The response 
of cells on a variety of substrates through measures such as gene expression will be critical to 
characterize as we work towards understanding cardiomyocyte function, or the development of 
cardiomyocyte therapies. 
The pHEMA platform used in this study to promote cell adhesion with controlled 
quantities of protein, while manipulating the substrate stiffness, may provide an attractive 
platform for cardiomyocyte culture where more stiff substrates are needed. Bridging the gap 
between studies conducted on TCPS and extremely soft, tissue-like substrates would allow for a 
more effective transfer of knowledge from one system to application in another. Additional 
testing to compare our gene expression results with a substrate of heart tissue-like stiffness as 
well as TCPS would be helpful to further characterize gene expression over this wide spectrum. 
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Chapter 6 
 
 
 
Skeletal muscle cells align across multiple cellular layers when cultured in deep and wide 
3D channels 
 
 
 
6.1 Introduction 
 
During skeletal muscle development, mononucleated myoblasts fuse to form long, 
multinucleated myotubes with aligned sarcomeres throughout their length.  These myotubes 
align along a common axis to allow the muscle to contract.  Recently, the complexity of this 
system has been amplified. A need to regenerate muscle for victims of disease, such as muscular 
dystrophy
1
, has driven tissue engineering efforts to mimic the muscle structure in vitro
2
. An 
established tissue engineering strategy of seeding a biomaterial scaffold with cells holds promise 
for regeneration of muscle tissue. However, muscle cells must remain viable within a scaffold, 
then align, fuse and differentiate into myotubes to be able to contract efficiently
1
. This process 
requires specific spatial cues, often referred to as contact guidance
3
, as well as biological cues. In 
traditional 3D biomaterial scaffolds, the necessary spatial cues are not present and therefore 
specialized topography must be developed.  
 Several approaches to engineer striated muscle have focused on contact guidance 
initiated by a biomaterial, whereby cells align parallel to the direction of physical constraint 
along their surface. Biomaterials have been developed specifically to induce muscle cell 
alignment through fabrication of patterns using soft lithography
4,5
 hot embossing
6
, 
photolithography and solvent casting
7
 or alternatively, through electrospun networks
4,8,9
. These 
approaches, which often incorporate small-scale topography on the order of tens of nanometers 
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to a few microns
4-12
, have achieved excellent cell alignment and elongation in 2D. This scale is 
based primarily on the dimensions of grooves in which myoblasts align in vivo, just prior to 
fusion with myotubes
13
. 
One additional goal for developing a surface that supports functional muscle cells is to 
induce differentiation. This fusion of myoblasts into multinucleated, organized myotubes is 
needed for efficient contraction of the muscle cells.  Differentiation of myoblasts into myotubes 
has been observed through measures such as lowered myoblast proliferation rate
4,5
, development 
of long multinucleated cells
5,7,9
, nuclei orientation along the axis of patterns
5
, presence of 
sarcomeric myosin
6,7,9
, and the development of aligned sarcomeres
9
.  
Although 2D surfaces or thin nano-scale features have been successful in promoting 
alignment of myotubes in single layers, muscle is comprised of multiple layers of cells. These 
densely-arranged layers allow the tissue to generate sufficient force to contract, and are therefore 
critical to the overall muscle function. Some skeletal or cardiac muscle tissue engineered systems 
have been developed to allow cells to dictate their own three-dimensional structure either along a 
surface or within a protein gel (e.g., collagen or Matrigel!), guided only by limited physical 
contact, such as pegs on each end of a muscle spindle
14,15
. Often, these constructs develop weak 
contraction. However, alignment of the cells on large length scales (i.e., throughout a bulk 
construct) has not been achieved without external mechanical or electrical stimulation, and the 
size of the construct often changes dramatically due to remodeling of the protein matrix. 
Unfortunately, the overall contractile properties of these engineered tissues still do not compete 
with native muscle
8
, a limitation that may be overcome with scaffolds that promote a more 
organized matrix. 
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In an effort to develop scaffolds that are capable of promoting alignment of muscle cells 
in three dimensions, the objectives of this study were twofold. First, we investigated whether a 
scaffold architecture presented in three dimensions in the form of long channels that are both 
deep and wide would be sufficient to guide cell alignment in 3D. Specifically, channeled 
hydrogel structures were fabricated from well-defined thiol-ene polymeric molds with 
dimensions ranging between 40 and 200 µm in width and 100 and 200 µm in depth. Skeletal 
muscle cells (C2C12) were seeded into the channels in multiple layers, and their alignment 
relative to the channel walls was assessed as a function of channel width, channel depth, and as a 
function of cellular layer. The second objective investigated whether scaffold architecture, and 
hence alignment, impacted the cells’ ability to differentiate into myotubes or multinucleated 
muscle fibers. Myotube differentiation was analyzed qualitatively by the presence of MHC IIb, 
which is characteristically upregulated during differentiation, and by real time RT-PCR to 
quantitatively track myotube formation within channels. Our findings demonstrate that 
macroscopic scaffold architectures are capable of promoting cell alignment when presented in 
3D. This information will serve as a foundation for developing new scaffolds for muscle 
regeneration.   
 
6.2 Methods 
 
6.2.1  Fabrication and characterization of molds 
Glass slides (VWR 48300-025) were cleaned with piranha solution (1:3 hydrogen 
peroxide to sulfuric acid) for 4 h, then rinsed three times in deionized water, rinsed once in 
acetone, and dried. Clean slides were reacted with 0.5 mL methacryloxypropyl-trimethoxysilane 
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(Gelest, Inc) at 80°C for 4 h under argon in a cylindrical Teflon! reaction vessel to functionalize 
the glass surface with methacrylate groups. Slides were stored at room temperature under argon.  
As shown in Fig. 6.1, a solution of 50% (w/w) pentaerythritol tetra(3-
mercaptopropionate) (PETMP), 40% (w/w) triallyl isocyanurate (TATATO), 0.5% (w/w) 2,2-
dimethoxy-1,2-diphenylethan-1-one (Irgacure 651, Ciba Specialty Chemicals) acting as the 
photoinitiator, and 0.5% (w/w) aluminum N-nitrosophenyl hydroxylamine (WAKO) acting as an 
inhibitor, were placed on a treated glass slide. The solution was covered with a second glass plate 
and a photomask. The mold configuration was lowered onto the monomer solution, such that the 
thickness of the monomer solution was a known value of either 100 or 200 µm, calculated by the 
mask alignment instrument. The monomer solution was exposed to UV light (365 nm, 15 
mW/cm
2
) for 4.2 s. The glass slide with the patterned polymer was removed, washed with 
methanol, then dried overnight.  The dried molds were again exposed to UV light for 30 min 
(365 nm, 4 mW/cm
2
) to ensure complete polymerization. 
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Figure 6.1. Diagram of a) mold fabrication using a photomask and UV-initiated polymerization, 
b) a side view of the channel mold, c) photopolymerization of a channeled hydrogel between a 
mold and glass slide, and d) the final hydrogel with channels. 
 
 
 
 
6.2.2  Analysis of channel mold dimensions 
 
Molds were dried and cut in cross-sections, then imaged using low vacuum scanning 
electron microscopy LVSEM (JSM-6480LV) at an acceleration of 1kV. A minimum of two sets 
of channels was imaged for a minimum of two different molds for each condition.  NIH Image J 
was used to determine the width and height of channel molds. Profilometry was used to verify 
these dimensions by analyzing the heights of five channels on each of two molds for each 
condition. 
 
6.2.3  Fabrication and characterization of hydrogel scaffolds 
A macromer solution was mixed to a composition of 20% (w/w) poly(ethylene glycol) 
diacrylate (PEGDA) and 0.01% (w/w) 1-[4-(2-hydroxyethoxy)-phenyl]-2-hydroxy-2-methyl-1-
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propane-1-one (Irgacure 2959, Ciba Specialty Chemicals) photoinitiator. Acryl-PEG-RGD was 
synthesized from acryl-PEG-NHS (MW 3400) (Laysan Bio) and the peptide sequence NH3-Tyr-
Arg-Gly-Asp-Ser-COOH (YRGDS, Genscript), characterized as previously reported
16
, then 
added to the PEGDA monomer solution at a concentration of  2 mM. The solution was poured 
into a template constrained on the top by the thiol-ene mold with a thin layer of Teflon spray to 
prevent sticking, on the bottom by an untreated glass slide, and on the sides by 0.8 mm thick 
Teflon! spacers. The macromer solution was polymerized for three minutes on each side for a 
total of 6 minutes under a 365 nm UV lamp (UVP, model XX-20BLB) at an intensity of 4 
mW/cm
2
. The mold was then removed from the polymerized hydrogel. Each hydrogel was 
soaked in a 70% ethanol solution to sterilize for a minimum of 6 hours with two solution 
changes. 
 
6.2.4  Analysis of hydrogel channel dimensions 
Hydrogels were fabricated as described above, with the addition of 0.05% (w/w) 
fluorescein-o-methacrylate (Aldrich, 568864) and hydrated in PBS overnight (n = 3).  Hydrogels 
were sectioned vertically, exposing cross-sections of the channel structures (n = 4). Confocal 
microscopy was used to image the channels in their hydrated form, and the dimensions were 
determined using NIH Image J. 
 
6.2.5  Skeletal muscle cell seeding and culture 
PEG scaffolds with channels were washed in sterile phosphate-buffered saline (PBS), 
channel side up, then equilibrated in medium (ATCC, 30-2002) with 20% fetal bovine serum and 
1% penicillin/streptomycin (Invitrogen).  Patterned sections of the hydrogel with channels less 
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than 7 mm in length were punched out into 7 mm diameter discs using a biopsy punch. 
Individual discs were placed in the wells of a 48 well plate. Skeletal muscle cells (C2C12, 
ATCC) between passages 3-15, were seeded into the wells at a density of 200,000 cells/cm
2
. 
Plates were centrifuged at 1000 rpm for 10 min, then removed and incubated for 75 min. After 
initial incubation, scaffolds were moved to 12-well plates in myotube differentiation medium 
(ATCC 30-2002) with 1% horse serum and 1% penicillin/streptomycin. Medium was changed 
every other day during the course of the study. 
 
6.2.6  Analysis of skeletal muscle cell alignment within channels 
Scaffolds were fixed with 4% paraformaldehyde for 20 min at room temperature, then 
stored in sterile phosphate-buffered saline (PBS) until use. Scaffolds were washed in 0.5% 
Triton-X in PBS at RT for 10 min, then incubated in a 1:40 concentration of phalloidin 488 
solution (200 units/mL, Invitrogen) for 20 min at room temperature. A 1:1000 DAPI (Invitrogen) 
solution was added to the scaffolds for 1 min at RT. Cells within scaffold channels were imaged 
while hydrated using confocal microscopy (Zeiss LSM5 Pascal). 
In each channel set, the fraction of elongated cells was first quantified. Each cell with a 
length-to-width ratio of greater than 2:1 was classified as elongated during analysis. Cells with a 
length-to-width ratio of less than 2:1 generally exhibited a rounded morphology. The proportion 
of elongated cells was quantified for each combination of channel width and depth. Cell viability 
was periodically verified through live/dead analysis and remained high throughout the study. 
 C2C12 alignment was measured for all elongated cells by determining the orientation in 
degrees of the cell relative to the channel wall (Fig. 6.2).  Briefly, a line was drawn through the 
long axis of each cell and the angle of the line relative to the channel wall was determined. A 
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degree of zero indicates that the cell is perfectly aligned and parallel with the channel wall, while 
a degree of 90 indicates that the cell is aligned perpendicular to the channel wall. The angle 
between the two lines (!) was used to assess alignment of each cell within the channel.  
 
 
Figure 6.2. Schematic of the angle of 
channel orientation based on the channel 
walls, where a) the cell in the channel 
has 0° orientation and b) the cell within 
the channel has a 45° orientation (! = 
45). 
 
  a.                              b.                    
 
 
 
The distribution of individual cell alignments for the population within each set of 
channel dimensions was analyzed through density plots and determination of the interquartile 
range. To create a density plot, a histogram was made from the ! values of each cell, within each 
set of channel dimensions. Instead of reporting the total cell count at each alignment value, the 
relative frequency density was plotted, where the product of the dimensions of an individual bar 
is the relative frequency. The use of density plots allowed direct comparison between alignment 
distributions of each channel set, as the total area under each histogram was 1. In addition to 
density plots, the interquartile range was determined for each channel set. The interquartile range 
was determined by subtracting the 25
th
 percentile from the 75
th
 percentile of the ! values for 
alignment, for each specific set of channel dimensions. These ranges are graphically represented 
as box plots for better visualization of the variance within each channel set. 
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6.2.7 Analysis of myotube formation within channels 
Channeled scaffolds were fixed at each time point in 4% paraformaldehyde for 20 min.  
After fixation, scaffolds were stored in PBS at 4°C.  Each scaffold was treated with 0.5% Triton-
X solution for 10 min, placed in a blocking solution containing 10% normal goat serum, 0.25% 
Triton-X and 2% BSA for 1 h at room temperature.  The block was removed, and a hybridoma 
supernatant (ATCC line HB-283) specific to rat myosin heavy chain IIb was applied to the 
scaffolds and incubated overnight at 4°C. The scaffolds were rinsed three times in PBS and a 
AlexaFluor 546 goat anti-mouse IgM secondary antibody (Invitrogen) diluted 1:200 was applied 
to the scaffolds for 1 h. After two PBS rinses, scaffolds were exposed to a 1:1000 DAPI solution 
for 1 min. The scaffolds were rinsed an additional three times in PBS, then imaged using 
confocal microscopy. 
 
6.2.8  Analysis of myotube gene expression using real-time RT-PCR 
Following the cell seeding procedure described above and the initial 75 min culture 
period, the surface of each channeled scaffold was scraped using a cell scraper to remove any 
cells that did not reside in the channels. The scaffolds were moved to a fresh well containing 
myotube differentiation medium, taking care to avoid disrupting cells settled in the channels 
during transfer. A Cells-to-Ct kit (Applied Biosystems) was used to isolate RNA from cells in 
channeled scaffolds and reverse transcribe the RNA into cDNA.  The following forward and 
reverse primers for myosin heavy chain IIb and a GAPDH housekeeping gene were designed 
using Primer Express software, and validated: MHC IIb forward 5’-3’: 
GAGGCCCCACCCCACAT ; MHC IIb reverse 3’-5’: ATTCTCACGATCCGTCAGCAT, and 
the housekeeping gene GAPDH forward 5’-3’: ATGGCCTCCAAGGAGTAAGAAAC, and 
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GAPDH reverse 5’-3’: GGGATAGGGCCTCTCTTGCT. Real-time RT-PCR samples were run 
on ABI Fast 7500, in 9600 emulation mode, and analyzed by relative expression of the gene of 
interest to the housekeeping gene (n = 5). C2C12’s cultured on 2D hydrogel films of the same 
chemistry as the channeled scaffolds served as controls for each time point. 
 
6.3  Results 
 
The widths of molds created using thiol-ene chemistry were faithful to the photomask 
dimensions (Fig. 6.3).  The height was reproducible within 20%, and could be obtained 
independent of fabrication width (Table 6.1). Each mold had uniform feature heights and widths 
after fabrication, with a variance of < 5% within one mold. After fabrication, no structural flaws 
(e.g., cracking, bending), which can arise due to shrinkage or swelling of the polymer, were 
detected. The shape of the rectangular channels formed into the hydrogels was similar to the 
mold shape, as seen in Fig 6.4. The dimensions of channels at the surface of fully hydrated 
hydrogel scaffolds were generally within 20% of the mold dimensions after fabrication and 
hydrogel swelling (Table 6.1, Fig. 6.4). !
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  40 µm wide 100 µm wide 200 µm wide 
100 µm deep 
Top view 
   
Cross-sectional view 
   
200 µm deep 
Top view 
   
Cross-sectional view 
   
Figure 6.3. Thiol-ene molds containing inverse channels ranging from 40-200 µm wide and 100-
200 µm deep, as seen in these top and side views. All scale bars = 500 µm. 
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Table 6.1. Dimensions for thiol-ene channel molds and channels created at the surface of 
hydrogels. Average values ± standard error of the mean are displayed. *indicates 
measurements taken in hydrated state 
Photomask 
feature width 
(!m) 
Measured 
mold width 
(!m) 
Measured 
hydrogel 
channel 
width (!m)* 
Mold 
fabrication 
depth (!m) 
Measured 
mold depth 
(!m) 
Measured 
hydrogel 
depth (!m)* 
40 54 ± 1 69 ± 3 100 105 ± 6 96 ± 3 
40 57 ± 1 66 ± 2 200 223 ± 6 184 ± 3 
100 119 ± 2 136 ± 3 100 120 ± 13 110 ± 2 
100 118 ± 2 131 ± 2 200 178 ± 2 233 ± 4 
200 220 ± 1 258 ± 4 100 94 ± 3 126 ± 5 
200 220 ± 2 246 ± 3 200 234 ± 3 235 ± 7 
 
 
 
 
40 µm wide                          100 µm wide                         200 µm wide 
 
 
 
100 
µm 
deep 
 
 
 
 
 
 
 
200 
µm 
deep 
  
Figure 6.4. Cross-sectional views of PEG channels polymerized with fluorescein-o-methacrylate 
to image hydrated channel dimensions. Scale bar = 200 µm. 
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Prior to characterizing alignment of muscle cells within channels, the proportion of 
elongated cells within channels of each dimension was quantified (Fig. 6.5). Thinner widths and 
deeper channels produced a greater number of elongated cells vs cells that did not have a specific 
orientation (i.e. round, triangular, etc.) within channels. All channels maintained > 50% 
elongated cells in culture. 
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Fig 6.5. The proportion of elongated cells in 
culture varied with channel width and depth, 
but was greater than 50% for all channel 
dimensions. 
 
 
Skeletal myoblasts seeded into hydrogel channels demonstrated alignment patterns that 
were dependent on the channel dimensions.  As the channel width decreased, the alignment of 
C2C12s in the direction of each channel increased as observed through a more narrow alignment 
distribution (Fig. 6.6a) and decreases in the interquartile range (Fig. 6.6b,c). Additionally, a 
greater channel depth promoted a smaller interquartile range, indicating greater cell alignment, 
within channels 40 and 200 µm in width. Channels 40 µm wide and 200 µm deep produced the 
smallest density distribution, with nearly all cells oriented within 15 degrees of the channel wall 
orientation. When the depth of the 40 µm wide channels was decreased to 100 µm, the majority 
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of C2C12s continued to align within the channels, but the distribution broadened. Although both 
100 and 200 µm deep channels with 100 µm width had mostly aligned cells (between -15 and 
15°), the interquartile range remained very similar between the 100 and 200 µm depths, in 
contrast to the trend observed for channels with greater (200 µm wide) and smaller (40 µm wide) 
widths. Finally, C2C12s within 200 µm wide, 200 µm deep channels were more likely to have 
larger numbers of cells oriented along the channel wall than oriented along another axis. The 
more shallow 200 µm wide, 100 µm deep channels did not show any preference toward 
alignment with the channel wall, as they had a random distribution. These results illustrate a 
clear dependence on both channel width and depth in overall C2C12 alignment. 
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Figure 6.6. The distribution of cell alignment 
within channels after 24 h culture time varied 
with width and depth (n = 100-250), as seen in 
this density plot for channel dimensions where 
the area under each curve = 1 (a). Between 10-
40 cells were analyzed per construct (n = 6). A 
box plot showing the interquartile range (b) for 
each width and depth combination illustrates 
changes in the distribution of cell alignment 
based on channel dimensions. The interquartile 
range of cell angle for each channel dimension 
is plotted to further illustrate differences in 
alignment distribution based on channel width 
and depth (c). 
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In addition to channel dimensions, the location of a cell within a particular cell layer 
affected its orientation relative to the channel wall. C2C12s adhered to the bottom surface of the 
channel within the hydrogel scaffold were observed spreading, while cells a few layers above the 
channel surface appeared better aligned with the channel walls (Fig. 6.7).  
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Figure 6.7. Images of C2C12s after detection of f-actin (green) and cell nuclei (blue), indicating 
differences in cell alignment observed within different layers of channels. Channel walls are 
aligned with vertical edges of the images. 
 
 
The majority of cells lining the bottom surface of 40 and 100 µm channels aligned within 
15 degrees of the channel wall orientation, as determined through angle density (Fig. 6.8). Cells 
directly in contact with the channel wall exhibited good alignment with the wall axis. Within the 
bottom layer of cells in 200 µm wide channels, there was little orientation observed relative to 
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the channel wall with the exception of the cells directly adjacent to the wall. However, within 
wide 200 µm channels, cells that made up the subsequent layers demonstrated a more narrow 
distribution of alignment angles than the bottom layer (Fig. 6.8a,c). Additionally, the total 
number of elongated cells vs non-elongated cells increased as cell layer moved further from the 
channel base (Fig. 6.8b). A increase in alignment, as observed by a decrease in interquartile 
range, was observed for 40 and 200 µm wide channels as the distance from the channel base 
increased, but little change was observed in the interquartile range for cells within the 100 µm 
wide channels (Fig 6.8c). 
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Figure 6.8. The 
density of cells at 
each angle from the 
channel wall, 
arranged by layer 
from the channel 
base, shows the 
distribution of cell 
alignment within 
channels 200 µm 
deep (a). The 
fraction of elongated 
cells analyzed for 
each condition 
varied with cell 
layer within the 
channel (b). The 
interquartile range is 
shown based on cell 
layer and channel 
width, for channels 
200 µm deep (c). 
Error reported as 
standard deviation. 
b. 
0.5
0.6
0.7
0.8
0.9
1.0
Channel width (µm)
F
ra
c
ti
o
n
 o
f 
e
lo
n
g
a
te
d
 c
e
lls
!
!
!
!
!
50 100 150 200
!
!
Cell layer
4
3
2
1
    c. 
0
10
20
30
40
50
60
Cell layer
In
te
rq
u
a
rt
ile
 r
a
n
g
e
1 2 3 4
!
!
!
!
!
!
!
!
!
!
Channel width (µm)
200
100
40
    
 
!!
! 122 
 The timeline of myotube formation from C2C12s seeded into channels was observed at 
one, three and six days. Real-time RT-PCR studies suggested an increase in MHC IIb expression 
between days 1 and 3, and again between days 3 and 6 of culture for cells within channels (Fig. 
6.9). However, no significant changes in expression were observed between cells cultured in 
channels of varied widths, nor between cells within channels vs cells on the 2D hydrogel 
controls.  
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Figure 6.9. Relative expression of MHC IIb in 
C2C12s cultured on a 2D hydrogel surface 
(channel width = 0) or within channels of a 200 
µm depth and widths varied at 40, 100 and 200 
µm. Error reported as standard deviation. 
 
 
An antibody for Myosin Heavy Chain IIb (MHC IIb) was used to examine development 
of myotubes within the channel structures. After one day of culture within the channels, the 
majority of cells remained mononucleated. However, by day 3, large, multinucleated cell 
structures were observed in all channel sizes (Fig. 6.10).  Muscle cells within channels 100 or 
200 µm wide had a larger, rounder appearance, but channels 40 µm wide promoted formation of 
long, spindle-like multinucleated cells. The intensity of the MHC IIb did not appear to change 
significantly throughout the course of this study. 
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40 µm wide 100 µm wide 200 µm wide 
   
Figure 6.10. The morphology of multinucleated cells that formed within channel structures was 
dependent on channel width. MHC IIb (green) was detected in the cell body, and nuclei are seen 
in blue after three days in culture. Channel walls are aligned with vertical sides of images. 
 
 
 
 
6.4 Discussion 
 
This work demonstrates that deep and wide channels fabricated into hydrogel scaffolds 
are capable of promoting 3D skeletal muscle cell alignment. The impact of channel width and 
depth significantly affected the percentage of elongated cells within channels and the C2C12 
alignment in relation to the channel wall. Furthermore, the cell location by layer within channels 
had an impact on the degree of alignment along the axis of the channel. The degree of skeletal 
muscle cell differentiation was examined as a function of channel width, and therefore, 
alignment of cells, within the channel. The results of this study will be useful in development of 
hydrogel systems for muscle tissue engineering where 3D cell organization is necessary. 
 A thiol-ene system was chosen for use in the development of channeled hydrogel 
scaffolds, due to several advantages. Very high aspect ratios, exceeding 10, can be obtained 
through this polymerization strategy
17
. Due to negligible shrinkage and swelling, the features’ 
ability to retain their shape is superior to many photopolymerized materials. Through this 
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method, molds were reproducibly made, then used to fabricate hydrogels with channels of 
controlled dimensions. The final width of the fabricated mold was ~10-30% wider than the 
photomask dimension, but yielded reproducible results from mold-to-mold. There was more 
variability in the height dimensions of the channels from mold-to-mold, due to the intrinsic 
variability of the mask alignment measurement system. In the future, using a spacer of known 
thickness for mold height control during fabrication could minimize this discrepancy. A slight 
curvature was observed at the base of the channel walls, which is attributed to the fact that light 
absorption will vary as a function of thickness. Nonetheless, a range of distinctly different 
channel widths and channel depths were achieved. Swelling of hydrogels post-fabrication led to 
final feature dimensions that were larger than the original mold dimensions, but generally within 
~20%.  
Studies have reported that for inducing alignment of skeletal myoblasts using contact 
guidance, small features are preferred, generally consisting of very thin (< 25 !m)
6
 and shallow 
(< 5 !m)
7
 dimensions.  However, a common finding is that improved alignment was observed as 
channel depth increased
5,7
, suggesting that depth may be an important dimension for controlling 
myoblast alignment. This study demonstrates that channels, which are relatively large in width 
and depth, do in fact promote alignment. Interestingly, the 3D culture containing multiple layers 
of myoblasts is critical to achieving alignment, particularly when the channel widths are large. 
While our findings are in agreement with many 2D studies
6,7,18,19
 in that muscle cell alignment is 
generally improved with small features (e.g., 40 !m in this study) and poor in large channels 
(e.g., 200 !m in this study) at least in the first layer of cells, we show that subsequent layers of 
cells lead to significant improvements in alignment suggesting an important role for 3D culture.  
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In the first layer, cells are in direct contact with the hydrogel surface where they attach to 
RGD ligands presented by the hydrogel and which support their adhesion and spreading. 
Qualitatively, the channel walls were critical to inducing cell alignment in this layer, where 
highly aligned cells were present adjacent to the channel walls, and the degree of alignment 
decreased as the distance away from the wall increased. In the thinner, 40 µm channels, many of 
the cells aligned, even at the bottom surface, which is likely due to the fact that roughly half were 
in contact with a channel wall. However, there were fewer cells contacting the walls in the larger 
channels, leading to poorer overall alignment. These findings suggest that the 3D features of the 
hydrogel provide critical spatial cues to the cells, but that cells respond primarily to cues from 
the hydrogel surface in closest proximity. 
Most interesting is the fact that subsequent layers of cells exhibited high degrees of 
alignment even in the large 200 !m wide channels. In the subsequent layers, the majority of cells 
are in contact with other cells and it is only the cells at the channel walls which have the ability 
to interact with the hydrogel surface. These findings suggest that the spatial cues presented by 
the channel walls may be able to propagate more readily when cells are interacting with other 
cells as opposed to interacting with a surface containing a very high number of cell-adhesive 
peptide sites, and a surface which is substantially stiffer than muscle
20
. Since previous studies 
have demonstrated that myoblasts, when cultured in 3D constructs without any external 
alignment cues, do not spontaneously align, it would seem likely that the 3D channel architecture 
is necessary for their alignment. However, additional cues are clearly playing an important role. 
Engler, et al.
20
 previously found that C2C12s seeded on top of a base C2C12 layer produced 
superior striation to the base layer, which was attributed to the mechanical properties of the 
underlying cells, suggesting that stiffness also plays a role. 
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Skeletal myoblasts may interact with each other either indirectly through cell-secreted 
matrix molecules or directly through cell-cell contacts, such as cadherins. In order to form 
myotubes, the myoblasts must spatially organize to be in close proximity to recognize like cells, 
adhere to these neighboring cells, align, and then fuse. Myoblasts are known to secrete several 
precursors of extracellular matrix proteins, as well as proteins involved in cell migration and 
muscle differentiation
21
. While skeletal muscle is comprised predominantly of cells, there is a 
complex extracellular matrix and basal lamina containing collagen I, III, and IV, fibronectin and 
laminin, whose secretion is known to be, at least partially, controlled by the cells themselves
22,23
. 
These molecules aid in cell migration needed for myoblasts to pack into close proximity and 
align prior to fusion. While the role of guiding cell alignment within the channel structures is not 
specifically known, it is likely the initial alignment is due to cell-matrix interactions.  
In addition to the role of cell-matrix adhesion in myoblast fusion, cell-cell interactions are 
very important. The mechanical role of cadherins, along with the myoblasts’ actin cytoskeleton, 
affect the organization of cells with respect to each other during the differentiation process
24,25
. 
An actin focus, which forms near the interface of two cells, helps direct the fusion and build the 
cytoskeletal contractile apparatus for the new fused cell. Because this actin structure guides 
direction of the cell, it is a key player in alignment of myocytes with each other. Due to their 
prominence in myoblast structural organization, cadherins and actin likely contribute to the 
process of myoblast alignment that has been observed within the channel structures, particularly 
in the cells that comprise the second plus layer within a channel. In future studies, the improved 
alignment of cells on top of other muscle cell layers could be further evaluated by investigating 
cadherin and actin density and spatial arrangement within C2C12s making up different layers in 
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the channels. While it is likely that cell-cell junctions, are playing a role in promoting cell 
alignment in the 3D channels, additional studies are necessary to confirm this hypothesis.  
In addition to examining the alignment and stacking of skeletal myoblasts within the 
channel, this study examined differentiation within the channel structures. Muscle cell alignment 
within seven degrees
4
 or ten degrees
6
 of the axis of material features has promoted 
differentiation. Therefore, the differentiation potential within our systems, where most cells are 
aligned within 15 degrees, is promising. We aimed to test the hypothesis that channels which 
produce a higher percentage of aligned C2C12s would promote more rapid differentiation into 
myotubes. 
As expected, myoblasts had not fused after one day in differentiation medium, but many 
multinucleated cells were observed by day three within all channel dimensions. Myosin heavy 
chain IIb is upregulated as myoblasts begin to differentiate into myotubes
26
, and was used during 
this study to qualitatively examine myotube differences in structure or differentiation. Although 
no changes in intensity of the stain were observed between different channel dimensions, it 
appeared that different channel widths promoted different types of myoblast fusion, based upon 
number of nuclei per cell and the overall shape of the cells. Even though the smallest channels 
supported adhesion of several cells across the width of a channel, the fused cells within those 
channels generally only maintained one nucleus across. There appeared to be more lateral fusion 
within the larger channels, resulting in several less-oriented nuclei throughout the width of each 
cell. It should be noted that delamination of some of the myotubes occurred in the scaffolds 
during immunohistochemical processing, and was most apparent in the more shallow channels 
(i.e., 100 !m depths).  The difference in the thinner versus thicker fused cell structures may have 
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been the result of better alignment within the thin channels, since the thin channels produced 
fusion and aligned nuclei more characteristic of that seen in vivo.  
Gene expression examining MHC IIb within channels of different widths suggested a 
baseline increase in expression over time in differentiation media, but no difference based upon 
channel structure over time. These results were interesting for several reasons. First, the cell-cell 
contact would be very different in a system where cells were cultured in 2D and exposed only to 
other cells side-to-side, with strong contacts between the hydrogel surface, than in a system 
where cells were packed in 3D and had high degrees of cell-cell contact in all directions. 
Additionally, the changes in alignment observed within the channels did not appear to impact 
MHC IIb expression as a function of time. This evidence indicates the myotube differentiation 
process is governed primarily by cues taken from the differentiation medium, once a base level 
of cell-cell contact has been established. Overall, three-dimensional arrangement of cells and cell 
alignment appeared to have minimal impact on the time scale of differentiation. 
 
6.5 Conclusions 
 
The hydrogel channel system investigated throughout this study promoted alignment of 
muscle cells multiple layers deep and wide within a polymer scaffold. Large channel structures 
could be reproducibly fabricated in hydrogel systems to study the effect of channel width and 
depth on alignment of skeletal myoblasts. Myoblasts successfully aligned in 3D within the 
structures, and alignment of cell layers improved as they built upon the bottom layer of cells. 
Furthermore, multinucleated myotubes were observed in all channel dimensions within three 
days of culture. In future studies, alignment could be further promoted within these large channel 
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structures by a combination of nanoscale features at the channel surfaces, and 3D cell stacking 
throughout the channel. 
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Chapter 7 
 
Conclusions and recommendations 
 
This thesis advances the understanding, development and characterization of hydrogels 
for use as a scaffold material in cardiac muscle tissue engineering. The studies herein establish a 
basis for tailoring the mechanical properties, surface biological groups and architecture of 
poly(2-hydroxyethyl methacrylate) (pHEMA) and polyethylene glycol (PEG) hydrogel systems 
to meet the specific requirements of muscle cells. 
 The first objective of this research gave insight into the role of crosslinking density and 
pore size on the tensile mechanical properties of hydrogel scaffolds designed for use in muscle 
tissue engineering. The heart expands and contracts constantly, and a scaffold designed for use 
with heart cells must therefore move dynamically with the range of heart motion. Porosity of a 
scaffold that will ultimately support cells in three-dimensions is critical, especially for cells with 
high metabolism, such as cardiomyocytes. 
When spherical pores of different diameters and hydrogels of different crosslinking 
densities were systematically varied, distinct trends were revealed. Increases in crosslinking 
density increased strength of the scaffolds, but decreased ultimate tensile strain. Conversely, both 
incorporation of pores into the hydrogel scaffolds and an increase in the average pore diameter 
increased the ultimate strain. This work allowed porous scaffolds to be tailored to fall within the 
desired range for muscle contraction. The p(HEMA) scaffolds tested during these studies had 
mechanical properties (quasi-static modulus and ultimate tensile strain) closer to that of native 
tissue, but pore size had a significant impact on the final mechanical properties. In future studies, 
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the crosslinking density of the pHEMA system must be controlled simultaneously with pore size 
to achieve desired tensile properties. A wider range of crosslinking densities was examined for 
PEG scaffolds, and very large differences in the modulus and ultimate strain were observed as a 
result. In contrast to the pHEMA scaffolds, the mechanical properties of PEG scaffolds were less 
dependent on the pore diameter, although there was a decrease in modulus and an increase in 
tensile strain after incorporation of pores. These findings suggest that for PEG scaffolds, pore 
size may be optimized without sacrificing mechanical strength. 
This study contributes to applications in heart muscle, but also within a broad spectrum 
of tissue engineering applications. Pores may be used to minimize graft rejection or promote 
angiogenesis when a biomaterial is implanted into the body. Many soft tissues experience 
dynamic load that must be well characterized if that tissue is to be mimicked with a biomaterial. 
The results of this work allow for deliberate design of polymer scaffolds to meet desired 
mechanical requirements of a tissue, while simultaneously incorporating a controlled porous 
structure. 
After examining the mechanical properties of hydrogel substrates for use in cardiac 
muscle tissue engineering, the cardiomyocyte response to different biologically-active groups 
tethered to a hydrogel surface was investigated. The hydrogel-based scaffolds used for this 
research have many advantages in tissue engineering, but lack the cell-adhesion moieties 
necessary for cell recognition. As a result, we desired to find a controlled method for attachment 
of biological moieties that promoted adhesion, viability and proper phenotype of cardiomyocytes 
adhered to the scaffold. Previous studies had demonstrated good cardiomyocyte adhesion to 
proteins, so collagen I and laminin proteins were covalently-bound to hydrogel surfaces for these 
studies. The cell-adhesive peptide arginine-glycine-aspartic acid (RGD) was also used, due to its 
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ability to be systematically incorporated into a hydrogel scaffold and independently promote cell 
adhesion to a synthetic surface. 
The type of cell-adhesive protein or peptide bound to the hydrogel surface was shown to 
affect cardiomyocyte morphology, arrangement of cytoskeletal proteins, number of adhesion 
sites, and gene expression. Overall, protein-modified hydrogel surfaces promoted good myocyte 
adhesion and phenotype by most measures, but peptide-modified surfaces promoted myocyte 
aggregation and little evidence of correct phenotype. Although similar numbers of cells attached 
to protein- and peptide- modified surfaces, the cells attached to protein surfaces showed striation 
and attachment through focal adhesions, whereas the cytoskeletal structure was circular and no 
striation or distinct focal adhesion sites were observed in cardiomyocytes cultured on peptide-
modified hydrogel surfaces. The gene expression profiles of cardiomyocytes on these surfaces 
were interesting, as they showed decreases in ANP for all conditions, as expected for maturing 
tissue, and increases in SERCA2a by day seven in culture in cardiomyocytes on protein-modified 
hydrogels only. From these measures, the protein-modified scaffolds appeared to promote a 
cardiomyocyte phenotype that was working towards maturation. However, the ratio of !- to "-
MHC was also analyzed, and yielded conflicting results. The ratio dropped over time for all 
protein- and peptide-modified conditions, as compared to the neonatal heart control, and 
therefore, failed to indicate maturation of the cardiomyocytes on any of the modified surfaces. 
The results of this study were interesting, since a lack of adhesion and spreading were 
observed in cardiomyocytes cultured on RGD-modified hydrogels. In contrast, skeletal 
myoblasts cultured on RGD-modified hydrogels with small (0.5 mM) concentrations of RGD 
adhered and spread readily on the surface. This suggests that synergistic interactions occur 
between the cell-adhesive moieties cardiomyocytes use to adhere to the extracellular 
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environment.  Further studies to elucidate the specific cell-adhesive peptides that contribute to 
cardiomyocyte adhesion could increase the versatility of using the hydrogel system for tissue 
engineering.  
The overall mechanical properties, and the cell recognition of a biomaterial, play a role in 
the success of tissue engineered scaffolds. In addition, the stiffness of a biomaterial can influence 
cell behavior, especially at the interface where a cell adheres to the material. Therefore, further 
mechanical analysis of hydrogel scaffolds was conducted, demonstrating that cardiomyocytes 
alter their gene expression levels depending on the scaffold stiffness. Many substrates have been 
used to culture cardiomyocytes, ranging from tissue-culture polystyrene (TCPS) to very soft 
hydrogels, namely polyacrylamide. While the heart has a low stiffness, estimated around 10-20 
kPa, many studies investigating cardiomyocyte maturation and re-entrance into a disease state 
during hypertrophy take place on non-compliant TCPS. In addition, a wide range of natural and 
synthetic tissue engineered scaffolds with different mechanical properties have been utilized for 
cardiac muscle tissue engineering, but the response of the cells within different studies cannot 
accurately be compared without knowledge of the effect of scaffold stiffness. 
To probe the effects of hydrogel stiffness on cardiomyocytes, pHEMA hydrogels were 
fabricated with varied crosslinking densities and functionalized with immobilized collagen type 
I, enabling the cells to attach and sense their underlying substrate. Several trends in gene 
expression were observed for genes within the fetal gene program over a wide range of hydrogel 
stiffness (varied between 350-4800 kPa). The fetal gene program was chosen for several reasons. 
This set of genes has a defined change in expression within rat hearts as the heart matures which 
is evident within several days after birth. Alternatively, this set of genes may exhibit an opposite 
response to a maturing heart where cardiomycoytes revert back to the fetal gene expression state 
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in diseased hearts. As such, it is a well-defined indicator of the maturational state of the heart. 
Further, several of the genes making up this profile are believed to change as a result of 
mechanotransduction after entering the disease state, meaning an increase in stiffness due to 
extra load on the diseased heart causes changes in the expression pattern of the fetal gene 
program.  
The results of this study highlighted the importance of stiffness on cardiomyocyte 
response, even when cells are adhered to substrates much stiffer than native tissue. The ratio of 
the ! to " isoforms of myosin heavy chain (MHC) generally increase as cardiomyocytes mature. 
During the study, this ratio was increased by day 3 in culture, but again decreased by day 7. 
Striation was not observed within the cells, so a mature contractile apparatus was not produced 
through these changes in MHC expression. However, the cells did respond to substrates over the 
week-long study. Two hormonal signaling proteins, atrial natriuretic protein (ANP) and brain 
natriuretic protein (BNP) were also examined. The natriuretic proteins are generally upregulated 
in a disease state and downregulated in normal, healthy tissue during maturation. Interestingly,  
BNP expression increased over time and decreased on more compliant substrates, but ANP 
expression did not change over the course of the study. The last gene examined in this work, 
SERCA2a, is generally upregulated as cardiomyocytes mature, since the protein is involved in 
calcium transport. However, no changes in SERCA2a expression were observed. Although the 
range of ultrastiff substrates used for this work did not span the range of native muscle tissue, the 
results of these studies aid in understanding the cardiomyocyte gene response to stiffness. This 
will continue to be useful for cardiac muscle tissue engineering efforts, as well as in the 2D study 
of cardiomyocyte biology and function, since materials with a wide range of stiffness continue to 
be employed.  
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The regulation of these genes could be further explored by lowering the modulus of the 
least stiff hydrogel condition, such that a hydrogel surface, with a stiffness close to the native 
heart, could be compared to the more stiff conditions. A greater understanding of cardiomyocyte 
adaption to biomaterials would be gained by comparing the contractile function of individual 
cardiomyocytes attached to hydrogels of each stiffness. Cardiomyocytes can beat on very stiff 
surfaces, although many studies indicate better alignment of sarcomeres and stronger contraction 
on soft substrates. By examining the contractile velocity of cardiomyocytes adhered to very hard 
and soft extremes, as well as a spectrum between, many questions would be answered as to how 
well cardiomyocytes adapt to surfaces with a stiffness different from the native heart, and the 
type of mechanical compromises the cell makes to continue to function. 
The last objective of this research was to develop a 3D channel system that could be used 
for culture of muscle cells, to determine whether alignment could be promoted within deep and 
wide channels, as opposed to 2D surfaces with thin (! 30 µm) features. Channels were 
successfully created using a thiol-ene chemistry capable of obtaining high aspect ratios, and 
skeletal muscle cells were seeded in channels up to 200 µm wide and 200 µm deep. Cell 
alignment on the scaffold is critical to achieve the necessary end-to-end junction formation 
between cells that allows them to contract synchronously. Although good alignment can be 
achieved on smaller features, larger dimensions are favorable for 3D arrangements where 
thicker, aligned aggregates could generate greater force. The channel structure for these studies 
was specifically designed to maximize cell density, maintain alignment, and maintain viability.  
A thiol-ene mold proved to be a precise, reproducible method to create channels for 
muscle cell alignment studies. Channels were fabricated within hydrogels easily and 
reproducibly, and the final hydrated dimensions were within 20% of the mold dimensions. 
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Alignment of the majority of C2C12s along the axis of the channel walls was observed within 
channels of 40 and 100 µm widths. Although the channels 200 µm wide didn’t demonstrate a 
majority of cell alignment, the cell location relative to the bottom of the channel made a 
difference in alignment. In channels 200 µm wide, the bottom layer of cells, adhered to the 
bottom wall of the channel, had a greater tendency to spread on the surface than align with the 
wall. However, the second, third and fourth layers of cells stacked on top of this first layer were 
statistically more likely to align. Further alignment of C2C12s within the channel structures 
could likely be promoted by creating a nanopatterned structure on the bottom surface of the 
channels. This would promote alignment of the bottom cell layer, and it is hypothesized that 
alignment within subsequent layers would increase. 
Some differentiation within the channels was observed, as multinucleated cells formed 
within channels of all dimensions tested. Detection of MHC IIb, a marker of differentiation of 
C2C12s into myotubes, did not reveal differences in expression between channels. However, the 
structure of the fused myotubes appeared different, with thicker, rounder structures in the 
channels of larger width (100 and 200 µm). To further characterize the differentiation patterns of 
this system, it would be useful to expand upon gene expression profiles and investigate MyoD 
and myogenin. These two genes are upregulated during early stages of myoblast fusion, and 
could therefore establish a more complete timeline of differentiation events within channel 
structures.  
The skeletal muscle cell line (C2C12) demonstrated promising alignment within these 
large channels. Although these muscle cells share some similarities with cardiomyocytes, they 
have been shown to react differently to cell-adhesive biological groups at the surface of 
hydrogels. Further studies would be needed to modify the covalently-bound biological groups at 
  
 140 
the surface of hydrogels with a channel structure. Due to the low adhesion of cardiomyocytes on 
RGD, the hydrogel scaffold would need to be modified with a whole protein. Additionally, the 
primary cardiomyocytes do not proliferate, whereas the skeletal muscle cells divide and migrate. 
As a result, studies would need to determine proper seeding density and seeding methods to 
promote viable, attached cardiomyocytes within the channel structures.  
In conclusion, the studies conducted within this thesis have led to an improved 
understanding of methods to increase compatibility of hydrogel scaffolds for use in heart muscle 
tissue engineering. Modifications to hydrogel crosslinking density and the incorporation of 
controlled pore sizes have allowed for incorporation of bulk porosity into a polymer scaffold, 
while still maintaining control over producing mechanical properties similar to those of the heart. 
Bioactive surface groups that promote adhesion, spreading, cytoskeletal striation and some gene 
expression markers indicating a healthy cardiomyocyte phenotype, have been established and 
incorporated into the hydrogel structure. The effect of surface stiffness of the hydrogel surfaces 
on cardiomyocyte gene expression patterns has been characterized. Lastly, a model for three-
dimensional culture of muscle cells was developed and successfully used to attain viable, aligned 
layers of muscle cells. In the future, these findings will provide the opportunity for increased use 
and development of PEG or pHEMA scaffolds for use in cardiac muscle tissue engineering, 
towards developing a tissue engineered patch that matches the mechanical properties of the heart, 
and can be successfully integrated into the heart through use of a porous biomaterial and 
functional, contracting cells. 
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